ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID
NODE_5_length_263381_cov_23.199_240 # 256387 # 256542 # -1 # ID=5_240;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.417	NODE_5_length_263381_cov_23.199_240 	256387	256542	-	Loose	800	23.8682	Chlamydia trachomatis intrinsic murA conferring resistance to fosfomycin	47.83	3003785	protein homolog model	n/a	n/a	fosfomycin	antibiotic target alteration	murA transferase	ATGGGTGGTTGGGGTGTTGACGTAACACGCCTACGTTCATTAGGTAGCACAATTGGACATAGAATAAATGCTGCAGGCGGTGCAATTCCTTTTATTAAAATCCTAAATGATATAGCATTAGCAGTGGATCAAAACGGTAGAGAGTTTGCCGCTTAG	MGGWGVDVTRLRSLGSTIGHRINAAGGAIPFIKILNDIALAVDQNGREFAA	MPGIKVFGETVLRGSVRVSGAKNATTKLLVASLLSDQRTILKNVPNIEDVRQTVDLCRVLGAIVEWDQQAQVIEIHTPRILLSKVPPQFSCVNRIPILLLGALLRRCPYGIFVPILGGDAIGPRTLHFHLEGWKKLGAEIVISDEGYWASAPNGLVGAHITLPYPSVGATENLILASVGAQGRTIIKNAALEVEIIDLIVFLQKAGVEITTDNDKTIEIFGCQDFYSVEHFIIPDKIEAASFGMAAVVSQGRIFVEQARHEHMIPFLKVLRSIGGGFSVHENGIEFFYDKPLKGGVLLETDVHPGFITDWQQPFAVLLSQSEGCSVIHETVHENRLGYLKGLVKMGAHCDLFHECLSAKSCRYSTGNHPHSAVIHGPTPLQATDLVIPDLRAGFAYVMAALIAEGGASWIENTEMLDRGYTDWRGKLERLGAKVLARDAVSVYV	11.49	gnl|BL_ORD_ID|2281|hsp_num:0	2291
NODE_66_length_87298_cov_20.8872_36 # 46479 # 47168 # 1 # ID=66_36;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.522	NODE_66_length_87298_cov_20.8872_36 	46479	47168	+	Loose	500	24.6386	OXA-325	71.43	3001513	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGTCTGCTTCCGTGTCTCGTCGTTTTTTATTTACTGGCGCAGTTGGGGGTGCCTCCATCCTGTTTTTAAGCGCTTGCAGCTCCGGGGCGTCTGTGGTGGCCGCAGAGCGCACAGATTACAGCGGTGAGGTATCGTTCGACAGTTTCCGCCGCGAAGGTGAATATACGGCACCTACCCGCACTGAGCCCGCTAAGAATGCTCCCGTACCAACACTTCCACACAACGTTAATGAGCACACAGTGGCGGGCCTATATTCCACCATTGGTTTTATAGCTGCGAGTGTTACATATGCCTACCAAACCGGTGATACGGGCCGGAATCTGCTTGATGGCGAATATCATAAACGCCTTGATACGGGTTCACAGTCTTCTAGTGACTCTAGCGATTCTAGTGATTCTAGCGATTACAAGATATGGTCTGAGGCTCCCGATATCAGGTTTACGTTGAAGGATCCTATGCCAACGCGTGAGGGCGATACGTACTCGTGGCCAGCCATAATGACGGCGAAACTGGGGAGCTTCCTGGTATCTGCCGGGCGTGCACGGGAGATACCAGCTGAAAGGCGGGAACAAAAATACGAAGGCACCATAAAAGCGAGGTACAGTGATGGCGTGTGGCGTCTCAATCTCGACGAGTTACTCAGCGACGATACAAACAGCAGGTCTTCGGGCGGGTCAAAAACTATCTAA	MSASVSRRFLFTGAVGGASILFLSACSSGASVVAAERTDYSGEVSFDSFRREGEYTAPTRTEPAKNAPVPTLPHNVNEHTVAGLYSTIGFIAASVTYAYQTGDTGRNLLDGEYHKRLDTGSQSSSDSSDSSDSSDYKIWSEAPDIRFTLKDPMPTREGDTYSWPAIMTAKLGSFLVSAGRAREIPAERREQKYEGTIKARYSDGVWRLNLDELLSDDTNSRSSGGSKTI	MYKKALIVATSILFLSACSSNTVKQHQIHTISANKNSEEIKSLFDQAQTTGVLVIKRGQTEEIYGNDLKRASTDYIPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQFAYQLAHKTLPFSKNVQEQVQSMVFIEEKNGRKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL	83.88	gnl|BL_ORD_ID|391|hsp_num:0	418
NODE_146_length_60935_cov_14.7402_13 # 10404 # 10565 # -1 # ID=146_13;partial=00;start_type=ATG;rbs_motif=TAAAAA;rbs_spacer=11bp;gc_cont=0.469	NODE_146_length_60935_cov_14.7402_13 	10404	10565	-	Strict	900	20.4014	PmpM	100.0	3004077	protein homolog model	n/a	n/a		antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGTTAAAAATTATGCCGAAAACCAGACAAAAAAAATCTGTCGCATACACGCGCACAGGCAACGGCACAGAAAACACCTTCGCTTACGACCGTCAGCACGAGCGGTTGCAGGGCATGCTGCTCACATGCAGCGGAAACAATATCATGCAAACGCAGAAGTAA	MLKIMPKTRQKKSVAYTRTGNGTENTFAYDRQHERLQGMLLTCSGNNIMQTQK	MNSPALPLSRGLRIRAELKELLTLAAPIMIAQLATTAMGFVDAVMAGRASPHDLAAVALGNSIWIPMFLLMTGTLLATTAKVAQRHGAGDQPGTGPLVRQALWLALLIGPLSGAVLWWLSEPILGLMKVRPELIGPSLLYLKGIALGFPAAALYHVLRCYTNGLGRTRPSMVLGIGGLLLNIPINYALIYGHFGMPKMGGPGCGWATGSVMWFMFLGMLFWVNKASIYRASQLFSRWEWPDRATIGPLVAVGLPIGIAVFAESSIFSVIALLIGGLDENVVAGHQIALNFSALVFMIPYSLGMAVTVRVGHNLGAGLPRDARFAAGVGMAAALGYACVSASLMLLLREQIAAMYSPDPAVIAIAASLIVFSALFQFSDALQVTAAGALRGYQDTRVTMIMTLFAYWGIGLPVGYSLGLTDWFQEPTGPRGLWQGLVVGLTGAAIMLCIRLARSARRFIRQHERLQREDAEAASVLGR	11.11	gnl|BL_ORD_ID|2297|hsp_num:0	2734
NODE_162_length_56989_cov_143.734_1 # 3 # 101 # -1 # ID=162_1;partial=10;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.525	NODE_162_length_56989_cov_143.734_1 	3	101	-	Strict	500	22.7126	SPG-1	100.0	3003720	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	SPG beta-lacatamase	GTGACTAATTTACAGCAGCTACACCAGCGATATCAGGAGTTTTGCACCAGGTATCCGAATGCCGCGGCGGATTTCTTAGGCGCCATCGAAGACGTGCTT	VTNLQQLHQRYQEFCTRYPNAAADFLGAIEDVL	MRPLILLASALAMTAPSGALAQSAEQRAKWNGPREPFRITGNLYYVGTSGLSAYLIAGPRGHVLIDGALPESAPLIAANIRKLGFKLSDVKYLLSNHSHVDHAGGLAELKRLTGAQMVANVADKPDLEAGTTIGRTDIADFPAVKVDRVIGDGDRLTLGPIALVAILTPGHTKGATSWTTRIGSKNVIFTSSISVAGQNLINNINYPNAAADFRASFAKLRALKADIFLSFHAEAFALDEKRARAQAGATDAFVDPNELSRQVDLAEKAFDATLAKQQAANADRR	11.58	gnl|BL_ORD_ID|2104|hsp_num:0	2235
NODE_164_length_56842_cov_18.8617_56 # 46969 # 47142 # -1 # ID=164_56;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.580	NODE_164_length_56842_cov_18.8617_56 	46969	47142	-	Loose	2000	21.1718	oqxB	36.36	3003923	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATGTTGTGGACTCTCTCAGTTCTCGCCGCGTGCGTCCTGTCGGGTGGACTCGGATACTTCGTCGGGTCGGAGGTGAAGGGGTTGCGCGATGAGGCCATTTTCGCTGCGTTCCTCAAGGAGGTCTCCGACGAGTCCGAGCAGATGAAGCTCCTTCTGGATTTGGACGACTGA	MMLWTLSVLAACVLSGGLGYFVGSEVKGLRDEAIFAAFLKEVSDESEQMKLLLDLDD	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	5.43	gnl|BL_ORD_ID|2196|hsp_num:0	2400
NODE_240_length_48318_cov_26.8956_14 # 10585 # 13188 # -1 # ID=240_14;partial=00;start_type=ATG;rbs_motif=AACAA;rbs_spacer=7bp;gc_cont=0.439	NODE_240_length_48318_cov_26.8956_14 	10585	13188	-	Loose	300	26.1794	dfrA22	46.15	3003018	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGAGAAATTTTCTATATATTTTTGGGATACTCTTTCTTCATATAACTTATGCACAAGAGCAGCAGATGGCAAAGGATACCCTCGCTACAGTAGCAGTGCAGGATACCCTTTCTCAAGCGCCTACGCTGACGGCGTTGGAAAGAGGACGTGAGTTCGTTATAGGAGGCATAGAAGTCAAAGGGGCGAAGCACTACAATGCACAAACCATTATCGTGGCTTCAGGACTAAAAGTGGGGGATAAGATTACCATTCCCAGCGAACGTTTTACCCGTATCATTCACAAGTTGTGGAAGTATCAGGTGTTCAATGATATAGATATCTATATCGCTAAAATTGAGGGGAATAAAGCTTTCTTGGAGTTTGTTATTCAGGAAATGCCTGAACTCACTGAGGTTAAGATTGACGGTATCCGCAAAAGAAAAGCTGAAGAGCTACTCAAAAAAATAGAACTGGATAAGGACAAACTCAAAGTCTCTAAAAAGGTCAATGAAAGCCTTATCGCTAAAACCAAATCCTATATCACCGATAAGTATCGCAAGGAAGGTTTTCTCAATACCAAAGTACATATCACCACACAACCTGTCGATTCATTGGGTACCAAGGAGCGTATGCTCATTCGTATAGATAGGGGGTATAAGGTGAAGATCAATCATATCTCTTTCGAGGGAAATGAGAAATTTGCAGATAGCAAGCTGCGCAGGCAGATGAAAAAGACCAAACAACGTTTCTTTGGTCGTTTCTGGAAGCGCTCTAAGTACGTACAAGATAAGTATAACGAGGACTTGGCTTCGCTCATTGACTTCTATAAAGAAAATGGATACCGTGATGCTCGTGTAAAACGCGATACGCTCTACGATGGAAAAGAGAATATCGACCTTAAAATCTCCTTGGAGGAAGGACGCAAATACTACTTCGGGGATATCAAGTTCTTAGGGAATACCATTTATAGTAACCAGATGCTTAGCCATATTCTAGGGCTGAAAAAAGGGGAAGTATATAACGGGGTACAGCTACGTAACCGTATCAATGACCCTAAAGACCCCGATGCCAATAGCATCTCCAACCTATACCAGAATACGGGTTACCTCTTCTCTCAGATCAACCCTGTTGAGACTTCGGTAGTCAATGACACTATCAATTTTGAGGTACGTATCCATGAGGGTAAGCAAGCACACTTTAATAATATAACGGTAACAGGTAATAATATCACCAACGATAGGGTGATCTACCGTGAGATGCGTACCCGTCCTGGGTATCTTTACTCCAAAGAGGACGTAATACGTACAGTACGTGAGCTTTCCCAGTTGGGTATCTTTGATGCGCAGAGTATCAACCCTCAGATCAAGAATCCCGACCCGAACTCTGGAACTGTAGATCTCGAATATGGTCTTACCGATAGTGGCTCTTCTAGCCAAATACAGCTACAAGGTGGTTATGGTGGGGGAGGTTTCATGGGTACCCTAGGGCTGAACTTTAACAACTTCTCTATACAAAACATATTTGATAAGAAGTCTTACCGTCCGCTTCCTATGGGAGATGCTCAAAAGCTAGCCTTGAACGTGAGTGTAGGTCGTGCTTATAGGGTAGGTAGCTTCTCCTTTATGGAACCTTGGTGGGGAGGAGAGCGACCTGTACAGTTCTCTCTCGGCTTCAACTATTCGGTGAGTTATGATTATAACTACTATACCTATGATGTGGATAAGAGCAAGCGCTTCTATATCACAGGGGTATATTTGGGATTGGCAAAACGCCTTCAGGTGCCTGATGACTATTTCCAACTCTCTCAGAACATAAGCTATAACTATTATGACCTGAGAAACTATAACACTACGCTCTTTACCTTCGGGAACGGACATGCCAACGCCTTGGCCTACACCGTCTCCCTAAGCCGACGCTCCAGCGGACCTAATCCTATTTTCCCTCTCGGAGGAAGTGATTTTACCATTACCGCCAAGCTCACCCCTCCTTATTCCTTGTTCAACGGGGTAGATTATAAGTCACTTATGGAACAACGCAATGTGGCAGAAGCCAATGGCAATGCCAATCGTATTTCGGAGATTGACCAAGAGCGATTTAAGTGGTTGGAGTTCTATAAGCTACGTTTGCAAGGAAACTGGTACTTGAATCTGGTAGATAAGCTCGTATTGCGCCCTTCGGTAGACTTTGGTTACTTGGGTTACTATAATAGGGACAGAGGTACCGTGCCTTTTGAACGCTTCATGGTAGGGGGCGACGGTATGTCCTACAACTCTCTCGAAGGACGTGAATACATACAGATGCGCGGTTATCCGAACCAATCTCTATCGGCACGCGACGGAGATGTGATCTATAATAAGTTCTCTCTCGAACTACGCTACCCTATCACCCTCAAGCCTATGGCTTCTATTTATGGATTGGTATTTGCCGAGGGAGCCAACTCATTCGGAACTTTCTCTCAGTACAATCCATTTGACATCAAGCGTTCCGCAGGTTTTGGTATTCGTATCTTTATGCCTATGCTTGGTATCCTCGGCTTTGACTTTGGGTATGGTTACGATGGTATCAACGGCCGCACTACCCCACATGGTTGGGAAACCCACTTTATCTTAGGACAACAATTCTAA	MRNFLYIFGILFLHITYAQEQQMAKDTLATVAVQDTLSQAPTLTALERGREFVIGGIEVKGAKHYNAQTIIVASGLKVGDKITIPSERFTRIIHKLWKYQVFNDIDIYIAKIEGNKAFLEFVIQEMPELTEVKIDGIRKRKAEELLKKIELDKDKLKVSKKVNESLIAKTKSYITDKYRKEGFLNTKVHITTQPVDSLGTKERMLIRIDRGYKVKINHISFEGNEKFADSKLRRQMKKTKQRFFGRFWKRSKYVQDKYNEDLASLIDFYKENGYRDARVKRDTLYDGKENIDLKISLEEGRKYYFGDIKFLGNTIYSNQMLSHILGLKKGEVYNGVQLRNRINDPKDPDANSISNLYQNTGYLFSQINPVETSVVNDTINFEVRIHEGKQAHFNNITVTGNNITNDRVIYREMRTRPGYLYSKEDVIRTVRELSQLGIFDAQSINPQIKNPDPNSGTVDLEYGLTDSGSSSQIQLQGGYGGGGFMGTLGLNFNNFSIQNIFDKKSYRPLPMGDAQKLALNVSVGRAYRVGSFSFMEPWWGGERPVQFSLGFNYSVSYDYNYYTYDVDKSKRFYITGVYLGLAKRLQVPDDYFQLSQNISYNYYDLRNYNTTLFTFGNGHANALAYTVSLSRRSSGPNPIFPLGGSDFTITAKLTPPYSLFNGVDYKSLMEQRNVAEANGNANRISEIDQERFKWLEFYKLRLQGNWYLNLVDKLVLRPSVDFGYLGYYNRDRGTVPFERFMVGGDGMSYNSLEGREYIQMRGYPNQSLSARDGDVIYNKFSLELRYPITLKPMASIYGLVFAEGANSFGTFSQYNPFDIKRSAGFGIRIFMPMLGILGFDFGYGYDGINGRTTPHGWETHFILGQQF	MNPESVRIYLVAAMGANRVIGNGPDIPWNIPGEQKIFRRLTEGKVVVMGRKTFESIGKPLPNRRTVVLSRQASYSAAGCAVVSTLSQAIAIAAEHGKELYVAGGAEVYALALPRADGVFLSEVHQTFEGDAFFPALDAAEFDVVSAETVQATITYTHSVYARRNG	525.45	gnl|BL_ORD_ID|1292|hsp_num:0	1356
NODE_476_length_32708_cov_42.3899_2 # 898 # 1269 # 1 # ID=476_2;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.594	NODE_476_length_32708_cov_42.3899_2 	898	1269	+	Loose	650	27.335	vanO	29.11	3002913	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	ATGGCACAACACAATAAATGGCAACGCAACATCAGCGCAATCCTCGCCACCAGCATCCTCGCAGGCGCACTTTCAGGCTGCACCATCTCCGACGACCCACTCACCAACGCCGTCGCCACAGCCGCCACCATCGGCGTAGCCAGCCTACTCTTCTTCAACACCAGCGACAACCACTACTACGACCGCGACTACAATCGCCTCCCTCGCGACTACCGCCCATCGCGCAACGCCCGCATAGAACGCATCCGCGATTACGACGACTACCGCCGCTACCGCAACAACTACGACCGCCGCAACTATCGCGACCAACGCGACTGGCGAGACGACAACCGCCGCCCATACCGCGACAATCCACAAAGAATGATATGGTAA	MAQHNKWQRNISAILATSILAGALSGCTISDDPLTNAVATAATIGVASLLFFNTSDNHYYDRDYNRLPRDYRPSRNARIERIRDYDDYRRYRNNYDRRNYRDQRDWRDDNRRPYRDNPQRMIW	MSRLKVGVIFGGASEEHPVSIKSAREVARSLDTEKYEPFWIGITTGGEWKLCDGPDADWENRSARPAVLSPDRSVHGLLVMEQGGYETVRLDLVFPVLHGKLGEDGAIQGLLELAGIPYVGCDIQGSAVCMDKALAYIVAKSAGIATPSFWVVAENEKVDADHLRYPVFVKPARSGSSFGVSKVTREDELPNALSAARQYDSKVLIEEAVAGSEIGCAVMGELFGLITGEVDRVDLSHGFFRIHQEDSPETGSENSTFIVPADISDESRRLVQETAKAIYRTLGCKGLARVDMFLTDDGRVVLNEVNTMPGMTSYSRYPRMMAAAGLPISDMIDRLISMTMHGKKR	35.55	gnl|BL_ORD_ID|1675|hsp_num:0	1754
NODE_703_length_25531_cov_19.2581_5 # 5182 # 5742 # 1 # ID=703_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.563	NODE_703_length_25531_cov_19.2581_5 	5182	5742	+	Strict	500	23.483	mphB	100.0	3000318	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGTCCCCAGCGAAGCGAGCAGGCTTGGGTCTTGCGCTCACCGGGGTGCTGTCGCTCAGCGCGTGTGGAGCGGGCAACGTCAATCTTGATCCGGCTCCAGATGCCGCCAACCCCGTATGCGCTTATGCGATGGTTGCTATGCCAGAAAAACTCGTTGGCCTACAGCAGCGTGAAACTACGGCGCAAGGAACGACTGCTTGGGGCGAACCAGCCTCCGTGATTCTCAAATGCGGTGTTACCGTTCAGGAACCCGTATCGGACCCATGCGCTGAGGTCAATGGGATAGATTGGGTGCTGCGTCCCAAGGATGCGCCAGAGAACTCAACACCGCCAGTCTCAGCGTCTTCCTCCGCCACTGCAGGCCCTGAAAACCGTGCGACGGGAACGTGGACGGCAACCACGTACGGACGAACGCCCGCCATTGAAGTAACCTTCGACGCAGATAAGGTTTCATCATCAACTCTTCTTGCTGAGCTCAACTCGGCGGTCAAACAAATTCCGTCTCAGAAGAAATGCACGAACATCAACGATACTCTCAACGGTGTCAAAACCGGAAAATAG	MSPAKRAGLGLALTGVLSLSACGAGNVNLDPAPDAANPVCAYAMVAMPEKLVGLQQRETTAQGTTAWGEPASVILKCGVTVQEPVSDPCAEVNGIDWVLRPKDAPENSTPPVSASSSATAGPENRATGTWTATTYGRTPAIEVTFDADKVSSSTLLAELNSAVKQIPSQKKCTNINDTLNGVKTGK	MSKDIKQVIEIAKKHNLFLKEETIQFNESGLDFQAVFAQDNNGIDWVLRLPRREDVMPRTKVEKQALDLVNKYAISFQAPNWIIYTEELIAYKKLDGVPAGTIDHNIGNYIWEIDINNVPELFHKSLGRVLAELHSIPSNKAAALDLVVHTPEEARMSMKQRMDAVRAKFGVGENLWNRWQAWLNDDDMWPKKTGLIHGDVHAGHTMIDKDANVTGLIDWTEAKVTDVSHDFIFNYRAFGEEGLEALILAYKEIGGYYWPKMKEHIIELNAAYPVSIAEFALVSGIEEYEQMAKEALEVQGS	61.59	gnl|BL_ORD_ID|1653|hsp_num:0	1731
NODE_887_length_21396_cov_65.8332_12 # 9383 # 9580 # 1 # ID=887_12;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.601	NODE_887_length_21396_cov_65.8332_12 	9383	9580	+	Strict	710	21.557	efrB	100.0	3003949	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; rifamycin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAAACTCTACCGCTACCTCACCGGACCGGATGACGCCTCGTTCTGCCGCCGCGTTACCGAAGCACTGCAAAACGGCTGGGAGCTGTACGGCAACCCCACCCTCACGTTCGACGGCGAACACATTATCTGCGGGCAGGCCGTCGTCAAGGAAAGCGACGGCGGCTACGACCCGGAAAAACCGCTGTCAGAATACTGA	MKLYRYLTGPDDASFCRRVTEALQNGWELYGNPTLTFDGEHIICGQAVVKESDGGYDPEKPLSEY	LDTCRIFRRNAKSPVNIAKHAKFIRRLKWLCSENMTGFSVLKLYVRKKKPLKGFKQVNHRFKWFGFKASFISGLMLPLVQMTAYGTYIGVAVLGSYYVVAGVIVVGQLQAFIQYIWQISQPMGNITQLSAALQSASASTMRIFEILDEPEEELNEQDVPLPEPILGSVEFENVSFSYDPEKPLIRNLNFKVDAGQMVAIVGPTGAGKTTLINLLMRFYDVTEGAIKIDGIDTKKMNRSDVRSVFGMVLQDAWLYKGTIADNIRFGKLDATDYEVVDAAKTANVDHFIRTMPDGYEMEINSEGDNVSLGQKQLLTIARAVISDPKILILDEATSSVDTRLEALIQKAMDRVMEGRTSFVIAHR	17.96	gnl|BL_ORD_ID|2217|hsp_num:0	2422
NODE_1080_length_18821_cov_26.2725_6 # 5134 # 5313 # -1 # ID=1080_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.700	NODE_1080_length_18821_cov_26.2725_6 	5134	5313	-	Strict	500	23.0978	OXA-12	100.0	3001407	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGACGACGTCCCCGTGCTAGCCGCAGCCGCGGCTGGCACGGGGCTGTGCAGGCAGGGCTGGCTGCCTGCCTGGCGGCGGGATGGGGGCGTCCGCAGCGCGGACCTGCCGCAACCATCCGCAAACATCCGGGACGCCGGAGTGCACAAAAAAGCCCGCATGCAGCGGGCGTTTTTGTGA	MDDVPVLAAAAAGTGLCRQGWLPAWRRDGGVRSADLPQPSANIRDAGVHKKARMQRAFL	MSRLLLSGLLATGLLCAVPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALMGYDSGFLVNEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQYVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYTANILKVSEVEGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKPGKQFASIKAKEEVLAALPAQLKKL	22.35	gnl|BL_ORD_ID|174|hsp_num:0	186
NODE_1096_length_18603_cov_5.08551_18 # 9566 # 9673 # -1 # ID=1096_18;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.389	NODE_1096_length_18603_cov_5.08551_18 	9566	9673	-	Loose	500	20.0162	ANT(4')-Ia	32.0	3002623	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(4')	ATGCGATACTCCACACTAAAGAGGCTTGTTGAGTTTTATGGCGAGCCTGGCATGACTGTAGGCGAGTTTTTAGAAATTATAAAAGGACTTAACAATGCTAACAAATAA	MRYSTLKRLVEFYGEPGMTVGEFLEIIKGLNNANK	MNMNGPASMAQKERLQTCQEIAKRLHEVYGNDVLAIGVYGSVSRGTDGPFSDIEMFCVLRDSAETVDKSYEWSAGPWKAEVNVCSASILLKDAATVEDRWPLTHGPYFSPLRLYDPEGFFQRLRLAAESPTKEDFRQAIHEILVGEMYEYVGKLRNVNRNGPSTYLPSLALRFAHYGAMLIGLHNQTLFSTGAMVLPEALKLPHRPKGFDHVAELAMSGDLAQPAKIVSACEDFWKGLVAWAAEHDYVIHSKRIPF	13.67	gnl|BL_ORD_ID|1659|hsp_num:0	1737
NODE_1113_length_18408_cov_11.4365_2 # 406 # 567 # 1 # ID=1113_2;partial=00;start_type=ATG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.340	NODE_1113_length_18408_cov_11.4365_2 	406	567	+	Strict	275	21.1718	AAC(6')-34	100.0	3003989	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGAAAAAGATTATTATGTTAACAATACTTGCTATGACTGTCGTCGGATGTGAGCTTGTCAGTCCTGATTATTGGAACAGAGTTGACAAAAGAATGGAAGAAAAAGGAACGAAATGTTACAAATATCCTAGTGGAAATGTATACTGCGAAGATACAAAATAG	MKKIIMLTILAMTVVGCELVSPDYWNRVDKRMEEKGTKCYKYPSGNVYCEDTK	MRIGDLIREDGGIAMLVYEAGPITVRELEEKDEISLASWLSNPDVLQYYEGRDNPHDVERVREHFYVDDDETRCIIKYEGKPIGYIQFYLLDEETLGEYGYNESDADCRTFATDQFIGEPDYWNRGIGTKLMTSMVEYLVFQRQADRIVMDPQAWNERAIACYEKCGFRKVRLLEKHEQHEGELRDCWIMEYRAERK	26.90	gnl|BL_ORD_ID|2239|hsp_num:0	2525
NODE_1118_length_18358_cov_21.5917_14 # 6723 # 6908 # 1 # ID=1118_14;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=12bp;gc_cont=0.323	NODE_1118_length_18358_cov_21.5917_14 	6723	6908	+	Loose	500	21.9422	tlrB conferring tylosin resistance	55.56	3001299	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGAACTTAACAAATTGTCCCGCTTGTCAAAAGCAAATCAGTAATTCAGCAGAAACGTGTCCTCATTGTGGACATCCTATCAAAAAAATAAGAGAGCAACAAAACTCTCTTGTAACAATGATTGTTATTATTGTTGTATGTTTAATAGCGTTCCTTGTTATCAAATTGCAAGGTTTATTCAAATGA	MNLTNCPACQKQISNSAETCPHCGHPIKKIREQQNSLVTMIVIIVVCLIAFLVIKLQGLFK	MRKNVVRYLRCPHCAAPLRSSDRTLRCENGHTFDVARQGYVNLLRRPTKLAADTTDMVAARAALLDSGHYAPLTERLAGTAGRAAGAGAPDCVVDIGGGTGHHLARVLEEFEDAEGLLLDMSKPAVRRAARAHPRASSAVADVWDTLPLRDGAAAMALNVFAPRNPPEIRRILRPGGTLLVVTPQQDHLAELVDALGLLRVRDHKEGRLAEQLAPHFEAVGQERLRTTLRLDHDALGRVVAMGPSSWHQDPDELARRIAELPGIHEVTLSVTFTVCRPLP	21.79	gnl|BL_ORD_ID|458|hsp_num:0	336
NODE_1430_length_15346_cov_14.6484_5 # 1682 # 3145 # -1 # ID=1430_5;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.378	NODE_1430_length_15346_cov_14.6484_5	1682	3145	-	Perfect	950	989.178	mel	100.0	3000616	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGAATTAATATTAAAAGCAAAAGACATTCGTGTGGAATTCAAAGGACGCGATGTTTTAGATATAAATGAATTAGAAGTATATGATTATGACCGTATTGGTTTAGTAGGAGCAAATGGTGCTGGAAAAAGCACTTTACTCAGGGTACTTTTAGGAGAATTAACTCCCCCAGGATGTAAAATGAATCGTCTGGGTGAACTTGCCTATATTCCCCAGTTGGACGAAGTAACTCTGCAGGAGGAAAAAGATTTTGCACTTGTAGGCAAGCTAGGTGTTGAGCAATTAAATATACAGACTATGAGCGGTGGTGAAGAAACAAGGCTTAAAATAGCACAGGCCTTATCGGCACAGGTTCATGGTATTTTAGCGGATGAACCTACGAGCCATTTAGACCGTGAAGGAATTGATTTTCTAATAGGACAGCTAAAATATTTTACAGGTGCACTGTTAGTTATTAGCCATGACCGCTATTTTCTTGATGAAATAGTAGATAAAATATGGGAACTGAAAGATGGCAAAATCACTGAGTATTGGGGAAACTATTCTGATTATCTTCGTCAGAAAGAGGAAGAACGTAAGAGCCAAGCTGCAGAATACGAACAATTTATTGCGGAACGTGCCCGATTGGAAAGGGCTGCGGAGGAAAAGCGAAAACAGGCTCGTAAAATAGAACAGAAGGCAAAAGGTTCTTCAAAGAAAAAAAGTACTGAAGACGGAGGGCGTTTAGCTCATCAAAAATCAATAGGAAGTAAGGAAAAAAAGATGTATAATGCTGCTAAAACCCTAGAGCACAGGATTGCGGCCTTAGGAAAAGTAGAAGCTCCGGAAGGCATTCGCAGAATTCGTTTCAGGCAAAGTAAAGCATTGGAGCTCCATAATCCATACCCTATAGTCGGTGCAGAAATTAATAAAGTATTTGGGGATAAGGCTCTGTTTGAAAATGCATCTTTTCAAATTCCGTTAGGAGCAAAAGTGGCGTTAACTGGTGGTAATGGAATCGGAAAAACAACTTTAATCCAAATGATCTTAAACCATGAAGAAGGAATTTCTATTTCGCCTAAGGCAAAAATAGGTTACTTTGCACAGAATGGTTACAAGTACAACAGTAATCAGAATGTTATGGAGTTTATGCAGAAGGATTGTGACTACAATATATCAGAAATTCGTTCAGTGCTAGCATCTATGGGGTTCAAACAGAACGATATTGGAAAAAGTTTATCTGTTTTAAGCGGTGGAGAAATTATAAAATTGTTGCTTGCTAAAATGCTCATGGGTAGATATAACATCCTAATAATGGATGAACCCAGTAACTTCCTTGACATACCAAGTTTAGAGGCTTTGGAAATACTAATGAAGGAGTACACCGGAACTATCGTGTTTATCACCCACGATAAACGATTACTCGAAAATGTAGCAGATGTAGTTTATGAAATTAGAGATAAGAAAATAAATCTGAAACATTAA	MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCKMNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHGILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGNYSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGGRLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGAEINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYFAQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLAKMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRDKKINLKH	MELILKAKDIRVEFKGRDVLDINELEVYDYDRIGLVGANGAGKSTLLRVLLGELTPPGCKMNRLGELAYIPQLDEVTLQEEKDFALVGKLGVEQLNIQTMSGGEETRLKIAQALSAQVHGILADEPTSHLDREGIDFLIGQLKYFTGALLVISHDRYFLDEIVDKIWELKDGKITEYWGNYSDYLRQKEEERKSQAAEYEQFIAERARLERAAEEKRKQARKIEQKAKGSSKKKSTEDGGRLAHQKSIGSKEKKMYNAAKTLEHRIAALGKVEAPEGIRRIRFRQSKALELHNPYPIVGAEINKVFGDKALFENASFQIPLGAKVALTGGNGIGKTTLIQMILNHEEGISISPKAKIGYFAQNGYKYNSNQNVMEFMQKDCDYNISEIRSVLASMGFKQNDIGKSLSVLSGGEIIKLLLAKMLMGRYNILIMDEPSNFLDIPSLEALEILMKEYTGTIVFITHDKRLLENVADVVYEIRDKKINLKH	100.00	gnl|BL_ORD_ID|1177|hsp_num:0	1231
NODE_1430_length_15346_cov_14.6484_6 # 3265 # 4482 # -1 # ID=1430_6;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.378	NODE_1430_length_15346_cov_14.6484_6 	3265	4482	-	Strict	800	780.015	mefA	96.3	3000615	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAAAAATACAACAATTGGAAACGAAAATTTTATGCAATATGGGCAGGGCAAGCAGTATCATTAATCACTAGTGCCATCCTGCAAATGGCGATTATTTTTTACCTTACAGAAAAAACAGGATCTGCGATGGTCTTGTCTATGGCTTCATTAGTAGGTTTTTTACCCTATGCGATTTTGGGACCTGCCATTGGTGTGCTAGTGGATCGTCATGATAGGAAGAAGATAATGATTGGTGCCGATTTAATTATCGCAGCAGCTGGTGCAGTGCTTGCTATTGTTGCATTCTGTATGGAGCTACCTGTCTGGATGATTATGATAGTATTGTTTATCCGTAGCATTGGAACAGCTTTTCATACCCCAGCACTCAATGCGGTTACACCACTTTTAGTACCAGAAGAACAGCTAACGAAATGCGCAGGCTATAGTCAGTCTTTGCAGTCTATAAGCTATATTGTTAGTCCGGCAGTTGCAGCACTCTTATACTCCGTTTGGGATTTAAATGCTATTATTGCCATCGACGTATTGGGTGCTGTGATTGCATCTATTACGGTAGCAATTGTACGTATACCTAAGCTGGGTAATCAAGTGCAAAGTTTAGAACCAAATTTCATAAGGGAGATGAAAGAAGGAGTTGTGGTTCTGAGACAAAACAAAGGATTGTTTGCCTTATTACTCTTAGGAACACTATATACTTTTGTTTATATGCCAATCAATGCACTATTTCCTTTAATAAGCATGGAACACTTTAATGGAACGCCTGTGCATATTTCTATTACGGAAATTTCCTTTGCATTTGGGATGCTAGCAGGAGGCTTATTATTAGGAAGATTAGGGGGCTTCGAAAAGCATGTATTACTAATAACAAGTTCATTTTTTATAATGGGGACCAGTTTAGCCGTTTCGGGAATACTTCCTCCAAATGGATTTGTAATATTCGTAGTTTGCTGTGCAATAATGGGGCTTTCGGTGCCATTTTATAGCGGTGTGCAAACAGCTCTTTTTCAGGAGAAAATTAAGCCTGAATATTTAGGACGTGTATTTTCTTTGATCGGAAGTATCATGTCACTTGCTATGCCAATTGGGTTAATTCTTTCTGGATTCTTTGCTGATAAAATCGGTGTAAATCATTGGTTTTTACTATCAGGTATTTTAATTATTGGCATTGCTATAGTTTGCCAAATGATAACTGAGGTTAGAAAATTAGATTTAAAATAA	MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAILGPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHTPALNAVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSLEPNFIREMKEGVVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEHFNGTPVHISITEISFAFGMLAGGLLLGRLGGFEKHVLLITSSFFIMGTSLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLIGSIMSLAMPIGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK	MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVFGPAIGVLVDRHDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWMVMIVLFIRSIGTAFHTPALNSVTPLLVPEEQLTKCAGYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSLEPNFIREMKEGIVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEYFNGTPVHISITEISFAFGMLAGGLLLGRLGSFEKRVLLITSSFFIMGASLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIKPEYLGRVFSLTGSIMSLAMPIGLILSGFFADRIGVNHWFLLSGILIIGIAIVCPMITEVRKLDLK	100.00	gnl|BL_ORD_ID|1891|hsp_num:0	1976
NODE_1573_length_14175_cov_8.96586_1 # 1007 # 1768 # 1 # ID=1573_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.378	NODE_1573_length_14175_cov_8.96586_1 	1007	1768	+	Loose	500	26.1794	OXA-328	68.42	3001516	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGATGAAGAAAAAACCTATTCTCTTGCTTTTAGCAGCTTCCGTAGTTTTCCTTCTGTTTTTATCAGCCTGCAGCTCCAATAAGGGAGGCGATACTAATGGTTCCAGTTCCGAAGTGCAAAAAACGAAAGAGGGAATTTATGAGCATCTAAAAAATGCAAAGAATGAAATTTGGTATGTAACTAAGGAAGTATCAAAAACCTCTTATCCTTCTTATATCTATATCTTCAACAAGGGAGAAGTCAAAGGTTATAATTTATTTGATGCTAATATAGAAGGGAAATCTTTCGGAGATTTAGCGCAGATGTCCGATAAGGAAATTATTGATTACTATGAAAGTCAGGAAGGGGCAGCTTTAAAAGGTCTCTCTGAGCAGGCAGATTCGTTTTATGCGAGTATCAATCAAAATGAGGTGTCTAAGGCAACATCTGAAGCGTATAAAAAATACGCAGACGGGAATGGCGAGCTTCCTGCTGTTAAGTACACGGTTAAGCTAGTGACAGATGAAAGTGGGACTGGTGTCGAAAGTGAGAATATCGATATCAATCTCTTGGGTGTCGGGCAACATGCATCAAGAGTTGGAGAATTTCCACATTATACTGCTGTCTTGAAGCATGTAACAAGCACTACTAAGATTTTTGATAGCACCTATAATGGTTTTGAAACAGAGGATGCTGCGAAACCTTTATTTGTTACTCGTAGTAAAAAGCAGTTTGACTTAGATACTACTAAAACAAATGCTAAGGGACTGGAAATAGAATAA	MMKKKPILLLLAASVVFLLFLSACSSNKGGDTNGSSSEVQKTKEGIYEHLKNAKNEIWYVTKEVSKTSYPSYIYIFNKGEVKGYNLFDANIEGKSFGDLAQMSDKEIIDYYESQEGAALKGLSEQADSFYASINQNEVSKATSEAYKKYADGNGELPAVKYTVKLVTDESGTGVESENIDINLLGVGQHASRVGEFPHYTAVLKHVTSTTKIFDSTYNGFETEDAAKPLFVTRSKKQFDLDTTKTNAKGLEIE	MYKKALIVATSLLFLSACSSNTVTQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGKTEEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLGNAMKASAIPVYQELAQRIGLDLMSKEVKRIGFGNANIGSKVDNFWLVGPLKITPQQETQFAYQLAHKTLPFSKNVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL	92.67	gnl|BL_ORD_ID|576|hsp_num:0	611
NODE_1809_length_12772_cov_21.189_4 # 3686 # 3811 # -1 # ID=1809_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.651	NODE_1809_length_12772_cov_21.189_4 	3686	3811	-	Strict	375	20.0162	vanXM	100.0	3002953	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanX; glycopeptide resistance gene cluster	ATGACGCACTGGCACTACGTCCTCATCGCCTACGGTCTTTCCCTGGTGGCCCTGCTGGCCGAGCTGGTCCTGCTGGCCGGCCGTCGCCGCCAGGCACGTCATCAACTGGAAGACAGCGGTTCATGA	MTHWHYVLIAYGLSLVALLAELVLLAGRRRQARHQLEDSGS	MEKGFTFLDEILNDVRWDAKYATWDNFTGKPIDGYEVNRIIGTYELADALLKVQELAFNQGYGLLLWDGYRPQQAVNCFLQWAAQPEDNRTKAKYYPNIDRTEMVSKGYVASKSSHSRGSAIDLTLYRLDTDELVPMGSGFDFMDERSHHEAKGITSNEAQNRRFLRSIMENSGFEAYSFEWWHYVLINEPYPYSCFDFPVK	20.30	gnl|BL_ORD_ID|1909|hsp_num:0	1996
NODE_2421_length_10116_cov_87.9385_11 # 7461 # 8261 # 1 # ID=2421_11;partial=00;start_type=ATG;rbs_motif=TAA;rbs_spacer=10bp;gc_cont=0.342	NODE_2421_length_10116_cov_87.9385_11	7461	8261	+	Strict	400	535.798	ErmF	99.25	3000498	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACAAAAAAGAAATTGCCCGTTCGTTTTACGGGTCAGCACTTTACTATTGATAAAGTGCTAATAAAAGATGCAATAAGACAAGCAAATATAAGTAATCAGGATACGGTTTTAGATATTGGGGCAGGCAAGGGGTTTCTTACTGTTCATTTATTAAAAATCGCCAACAATGTTGTTGCTATTGAAAACGACACAGCTTTGGTTGAACATTTACGAAAATTATTTTCTGATGCCCGAAATGTTCAAGTTGTCGGTTGTGATTTTAGGAATTTTGCAGTTCCGAAATTTCCTTTCAAAGTGGTGTCAAATATTCCTTATGGCATTACTTCCGATATTTTCAAAATCCTGATGTTTGAGAGTCTTGGAAATTTTCTGGGAGGTTCCATTATCCTTCAATTAGAACCTACACAAAAGTTATTTTCGAGGAAGCTTTACAATCCATATACCGTTTTCTATCATACTTTTTTTGATTTGAAACTTGTCTATGAGGTAGGTCCTGAAAGTTTCTTGCCACCGCCAACTGTCAAATCAGCCCTGTTAAACATTAAAAGAAAACACTTATTTTTTGATTTTAAGTTTAAAGCCAAATACTTAGCATTTATTTCCTGTCTGTTAGAGAAACCTGATTTATCTGTAAAAACAGCTTTAAAGTCGATTTTCAGGAAAAGTCAGGTCAGGTCAATTTCGGAAAAATTCGGTTTAAACCTTAATGCTCAAATTGTTTGTTTGTCTCCAAGTCAATGGTTAAACTGTTTTTTGGAAATGCTGGAAGTTGTCCCTGAAAAATTTCATCCTTCGTAG	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIILQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISCLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVAIENDTALVEHLRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIVLQLEPTQKLFSRKLYNPYTVFYHTFFDLKLVYEVGPESFLPPPTVKSALLNIKRKHLFFDFKFKAKYLAFISYLLEKPDLSVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWLNCFLEMLEVVPEKFHPS	100.00	gnl|BL_ORD_ID|586|hsp_num:0	621
NODE_3218_length_8072_cov_22.5215_1 # 2 # 124 # -1 # ID=3218_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.577	NODE_3218_length_8072_cov_22.5215_1 	2	124	-	Loose	550	22.3274	LRA-2	53.85	3002485	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	subclass B3 LRA beta-lactamase	ATGCCCGTTTTTTCCCGCAAAGGCATAGACTGCCCGCAATGCGCCGAGTTTAAAACACGCGTGAAAATGGAAGGCGCGGCGCATTTGCAGCGCACGCTGTGCCATGTTGAAACCGCCGTGTCG	MPVFSRKGIDCPQCAEFKTRVKMEGAAHLQRTLCHVETAVS	MMDGIKKKTAAGAAAGSLLMMLGVFATPAAGGEAAFKDCPQCAQWNQQRKPFRIYGNTYFVGTAGLSSILVTSDYGHVLIDGGLAQSAPLIKANIEALGFKLTDVKAILVSHVHPDHAGGVAELQRQSGAQVYALRTAEAVLRTGRLTQDDPQSASKTATITPVPQVWVVQDDQLLGVGALRMRAIATPGHTPGGTSWTWDACEDGNCLKMIYADSLSAVAAGKYRFKDHPEVLQAFASSFSRAESAPCDVLLTPHPDASQLFQRLDPEGGTRAASIKDDTACRRYVQAARDTLARKLASEG	13.58	gnl|BL_ORD_ID|1265|hsp_num:0	1324
NODE_3557_length_7481_cov_19.1025_1 # 1 # 63 # -1 # ID=3557_1;partial=10;start_type=ATG;rbs_motif=AAAA;rbs_spacer=15bp;gc_cont=0.413	NODE_3557_length_7481_cov_19.1025_1 	1	63	-	Loose	1100	19.2458	tetB(60)	52.94	3004036	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGGTAGTGATAAAAAAGGTTTTTTGACGGGTCTGACTTGTCGGACAAATTGGACTGGTCTG	MGSDKKGFLTGLTCRTNWTGL	MRTMKRLLSYLRYEKKGVLIGLFCLLLSTGATLTGPLVAKHIIDNVITPMGQAHDFKAGGLLLWVGIYVTVNLVGVAGAYLNRVYMKTLSNRIAKRIRDEVFEHVQTLPVSYFDHLPAGKVVSRITSDTESVRANFYVSGISTLFSTIVMLVGVYITIFLLNATLGLVLLFLVPVMILWQRTVATKQKKYYSENRELYSQLSGQLNESIQGAGIVQAFQQEEKIVAEYDATATSWVEVGRKELILESYFSWSLVGMLRNITHFGVIYYFSMQFIGGTLGISAGLLYAFIDYINRIYEPIQTFMNVVSGFQQSMAAGDRVFELMDTPSEESGEELFTFDEGCIEFKDVSFEYTAGVPVLKHLNFTVEPGQTVAFVGHTGSGKSSIMNLLFRFYDPTSGAIFIDGKNTRDFNRRSVRSEMGIVLQDPYLFTGTIASNVGLNNESIEPETIKEAIIKVGGGHLLTKSDKGLDYEVKEKGMDFSSGERQLISFARAIVFDPKILILDEATSHIDTETEEIIQNAINVVKEGRTTFMIAHRLSTIAHADQIFVLDKGEIVERGTHDELLQLQGQYAEMVALQKG	3.63	gnl|BL_ORD_ID|2252|hsp_num:0	2646
NODE_3761_length_7140_cov_25.9953_8 # 7008 # 7139 # 1 # ID=3761_8;partial=01;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.576	NODE_3761_length_7140_cov_25.9953_8 	7008	7139	+	Loose	260	20.7866	msrB	30.77	3002818	protein homolog model	n/a	n/a	macrolide antibiotic; streptogramin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGGGAAACTCACTACCGGGCACCGGGAAGATTGAGAAAAACTGGCGTGAAATCCTCACCCCTGAGGAGTATGCGGTGCTGCGTGAAGGCGGCACCGAACGAGCCTTCACCGGCGAATACTGGGACACGAAA	VGNSLPGTGKIEKNWREILTPEEYAVLREGGTERAFTGEYWDTK	MANKPSAEELKKNLSEMQFYVTQNHGTEPPFTGRLLHNKRDGVYHCLICDAPLFHSQTKYDSGCGWPSFYEPVSEESIRYIKDLSHGMQRIEIRCGNCDAHLGHVFPDGPQPTGERYCVNSASLRFTDGENGEEING	32.12	gnl|BL_ORD_ID|2258|hsp_num:0	2653
NODE_5140_length_5572_cov_4.7631_1 # 924 # 2843 # 1 # ID=5140_1;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.412	NODE_5140_length_5572_cov_4.7631_1	924	2843	+	Strict	1200	1201.42	tet32	89.97	3000196	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAAAATAATCAATATTGGAATTCTCGCCCATGTAGACGCAGGAAAAACAACATTGACGGAAAGCCTGCTGTACACCAGTGGAGCGATTGCGGAACAAGGAAACGTGGATAAAGGAACTACAAGAACAGACACTATGATTTTGGAACGGCAGCGCGGAATTACCATTCAGACAGCGGTTACTTCTTTTTGCTGGAATGATTATAAAATCAATATCGTGGACACTCCCGGTCATATGGATTTTTTAACCGAAGCATACCGCTCTTTATCTGTCCTTGACGGAGCTGTTTTAGTCATTTCGGCAAAAGACGGCGTACAGGCACAAACCCGTATATTATTCCATGCGCTTCAGAAAATGGACATTCCGACAATTATCTTTATAAATAAGATAGACCAAAATGGGATCGACCTGCGGCGTGTTTACCAAAGCATTAAAGATAAACTTACCAGTGATATGATTGTCATGCAGGAGGTTTCCCTGTCGCCAAAGATAACCATGACCGATATTTCTGATTTGGACAAATGGGATATGATTATTTCCGGAAGCGATGAACTATTAGAACGATATGTTGCAGAGGATTCTTTGGATATACAGGAATTACAATATGAAAAGTGCAAAAGAACCAGATGCTGCTCTTTGTTTCCTGTTTATCATGGGAGTGCAAAAGACAATTTAGGAACAGAAAAACTGATTGAAGCGATTACAGAAACTTTCATTACAGAAACAGACGATATTCAGTCTGAATTATGTGGATATGTTTTTAAGGTTGAGTATACAGAGCGGAAAAAACGGCTTTCTTATTTACGCCTGTATCATGGGACGCTCCATTTACGGGATACCCTGCTGCTGTCAAAAAAGGAAAAAATAAAGATTACAGAAATGTGTATTCCGTCAAATGGTGAAATCGTCCCGGTTGACCATGCCTGTCCGGGAGAAATTGTTATTTTAGCTGATGATACTTTGAAACTGAACGACATTCTGGGAAATGAAAAACTCCTGCCTCACAAAACACGGATTGATAATCCCATGCCATTACTTCGGACAACGGTAGAGCCGCAAAAGCCGGAGCAAAGGGAAGCCCTGTTAAATGCCCTCACAGAGATTGCTGATACAGACCCTCTTTTGCATTTTGACATTGATACTGTTACACATGAGATTATATTATCTTTTTTGGGAAAAGTACAGTTAGAAGTTATTTGTTCGCTATTAGAAGAAAAATATCATGTGGGCGTGGCTATGAAAGAGCCTTCGGTTATTTATCTGGAAAGACCGCAAAAAAAAGCGAGCTACACGATTCATATTGAAGTGCCGCCGAATCCGTTTTGGGCATCTATTGGTTTGACTGTAACACCGCTTCCTGTTGGAAGCGGAACACAATATAAAAGCGAGGTATCTCTCGGCTATTTAAACCAAAGTTTTCAAAATGCCGTCATGGAGGGTGTGCGTTATGGAATGGAGCAGGGCTTATATGGCTGGGGAGTGACAGACTGCCAAATTTGTTTTGATTATGGAGTTTATTACAGCCCGGTCAGCACCCCCGCTGATTTTCGTTTTCTTGCGCCTGTCGTGTTGGAGCAGGCATTGAAAAAAGCAGGAACACAACTGTTGGAACCATACCTTTCCTTTACCCTTTTTGCACCGCAGGAATATCTTTCACGGGCTTATAATGACGCACCAAAGTATTGCGCAATCATTGAATCAACCAGACTTGAAAAAGATGAAGTTATTTTTAAGGGTGAAATCCCTGCCCGTTGTATCGGTGAATATAGGAATGATCTGAATTTTTATACAAATGGAAGAAGTGTCTGCATTACAGAATTAAAAGGGTATCAGGAAACTTCCGGCGAGCCTGTATTTCAGCCACGCCGCCCGAACAGCCGTTTAGACAAGATCCGGCATATGTTTCAGAAGATAATGTAA	MKIINIGILAHVDAGKTTLTESLLYTSGAIAEQGNVDKGTTRTDTMILERQRGITIQTAVTSFCWNDYKINIVDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMDIPTIIFINKIDQNGIDLRRVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIISGSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAITETFITETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNGEIVPVDHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREALLNALTEIADTDPLLHFDIDTVTHEIILSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIYLERPQKKASYTIHIEVPPNPFWASIGLTVTPLPVGSGTQYKSEVSLGYLNQSFQNAVMEGVRYGMEQGLYGWGVTDCQICFDYGVYYSPVSTPADFRFLAPVVLEQALKKAGTQLLEPYLSFTLFAPQEYLSRAYNDAPKYCAIIESTRLEKDEVIFKGEIPARCIGEYRNDLNFYTNGRSVCITELKGYQETSGEPVFQPRRPNSRLDKIRHMFQKIM	MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAVTSFQWEDVKVNIIDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMNIPTIIFINKIDQNGIDLQRVYQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIISGSDELLERYVAEDSLDIQELQYEKCKRTRCCSLFPVYHGSAKDNLGTEKLIEAITETFITETDDIQSELCGYVFKVEYTERKKRLSYLRLYHGTLHLRDTLLLSKKEKIKITEMCIPSNGEIVPVDHACPGEIVILADDTLKLNDILGNEKLLPHKTRIDNPMPLLRTTVEPQKPEQREALLNALTEIADTDPLLHFDIDTVTHEIILSFLGKVQLEVICSLLEEKYHVGVAMKEPSVIYLERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEGVLYGCEQGLYGWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEYLSRAYHDAPRYCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQPRRPNSRIDKVRHMFHKLA	100.00	gnl|BL_ORD_ID|1179|hsp_num:0	1233
NODE_5458_length_5316_cov_6.97339_1 # 2 # 166 # -1 # ID=5458_1;partial=10;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.327	NODE_5458_length_5316_cov_6.97339_1 	2	166	-	Loose	600	25.7942	cepA	41.67	3003559	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	cepA beta-lactamase	ATGAAAAAAGTATATTGTTACCCAAGATGCACAACTTGTAAAAAGGCTGTGAAATGGCTGGAAGAAAATGGGATTGATTATGAATATAAGCACATTGTGGAAGAAACACCGTCGAAGGAAGATATTAAGAAATATTATAAAGAAAGTGGATTGCCGTTAAAAAGA	MKKVYCYPRCTTCKKAVKWLEENGIDYEYKHIVEETPSKEDIKKYYKESGLPLKR	MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDIHYPMMSVFKFHQALALADYMHHQKQPLETRLLIKKSDLKPDTYSPLRETYPQGGIEMSIADLLKYTLQQSDNNACDILFNYQGGPDAVNKYLHSLGIRECAVIHTENDMHKNLEFCYQNWTTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGDRNAKGQQIGCNDIGFILLPDGHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID	18.33	gnl|BL_ORD_ID|1603|hsp_num:0	1677
NODE_5799_length_5051_cov_32.6393_4 # 3906 # 4643 # -1 # ID=5799_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.333	NODE_5799_length_5051_cov_32.6393_4	3906	4643	-	Strict	400	493.812	ErmB	98.78	3000375	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAACAAAAATATAAAATATTCTCAAAACTTTTTAACGAGTGAAAAAGTACTCAACCAAATAATAAAACAATTGAATTTAAAAGAAACCGATACCGTTTACGAAATTGGAACAGGTAAAGGGCATTTAACGACGAAACTGGCTAAAATAAGTAAACAGGTAACGTCTATTGAATTAGACAGTCATCTATTCAACTTATCGTCAGAAAAATTAAAACTGAATACTCGTGTCACTTTAATTCACCAAGATATTCTACAGTTTCAATTCCCTAACAAACAGAGGTATAAAATTGTTGGGAATATTCCTTACCATTTAAGCACACAAATTATTAAAAAAGTGGTTTTTGAAAGCCGTGCGTCTGACATCTATCTGATTGTTGAAGAAGGATTCTACAAGCGTACCTTGGATATTCACCGAACACTAGGGTTGCTCTTGCACACTCAAGTCTCGATTCAGCAATTGCTTAAGCTGCCAGCGGAATGCTTTCATCCTAAACCAAAAGTAAACAGTGTCTTAATAAAACTTACCCGCCATACCACAGATGTTCCAGATAAATATTGGAAGCTATATACGTACTTTGTTTCAAAATGGGTCAATCGAGAATATCGTCAACTGTTTACTAAAAATCAGTTTCATCAAGCAATGAAACACGCCAAAGTAAACAATTTAAGTACCGTTACTTATGAGCAAGTATTGTCTATTTTTAATAGTTATCTATTATTTAACGGGAGGAAATAA	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESRASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTVTYEQVLSIFNSYLLFNGRK	MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELDSHLFNLSSEKLKLNTRVTLIHQDILQFQFPNKQRYKIVGSIPYNLSTQIIKKVVFESRASDIYLIVEEGFYKRTLDIHRTLGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNREYRQLFTKNQFHQAMKHAKVNNLSTITYEQVLSIFNSYLLFNGRKLIL	98.79	gnl|BL_ORD_ID|1477|hsp_num:0	1549
NODE_6362_length_4687_cov_29.1438_5 # 1459 # 1590 # 1 # ID=6362_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.356	NODE_6362_length_4687_cov_29.1438_5 	1459	1590	+	Strict	400	20.4014	CRP	100.0	3000518	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAAACATTGGAATGGTTTTTGTCATTAAACGGCTGGGACTTTTTCTGGGCATTAGTAAAGTTGTATTTCTTACTCGCTGTGCTGGGTACATTTTTGAGATATGTATTTTGGCACAAAGAAAACGATTAA	METLEWFLSLNGWDFFWALVKLYFLLAVLGTFLRYVFWHKEND	MVLGKPQTDPTLEWFLSHCHIHKYPSKSKLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISYKKFRQLIQVNPDILMRLSAQMARRLQVTSEKVGNLAFLDVTGRIAQTLLNLAKQPDAMTHPDGMQIKITRQEIGQIVGCSRETVGRILKMLEDQNLISAHGKTIVVYGTR	20.48	gnl|BL_ORD_ID|836|hsp_num:0	869
NODE_6712_length_4482_cov_32.0459_1 # 438 # 680 # -1 # ID=6712_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.551	NODE_6712_length_4482_cov_32.0459_1 	438	680	-	Strict	600	23.483	cipA	100.0	3003907	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	ATGGATACAGTAGTTTCAACACGCAGCCGCCCGAAGGCGGCTGAAATGCGTAGTCTGAACGGATTCGGCTGTACTTTTTGTTTCAACACGCAGCCGCCCGAAGGCGGCTGGTCGCGCGATTTGCTGGTGGGCGCAAGCTGGATGTTGTTTCAACACGCAGCCGCCCGAAGGCGGCTGAAGCTTCATCCTCTTTTTATTATGATTCCGATTGGTTTCAACACGCAGCCGCCCGAAGGCGGCTGA	MDTVVSTRSRPKAAEMRSLNGFGCTFCFNTQPPEGGWSRDLLVGASWMLFQHAAARRRLKLHPLFIMIPIGFNTQPPEGG	MKYLSKYEKIRKILSALNQPNYRYSQITEAIFKNKIGNFEAMNNLPKPVRNELIKELGNNVLSITPKMEQKSNQVSKILFAIPGDEYIESVRLSYQTGWESYCISSQCGCGFGCTFCATGTLGLKRNLTTDEITDQLLYFTLNNHPLDSVSFMGMGEALANPYVFDALHLLTDPKLFGLGHRRITVSTIGLLPGVKKLTKEFPQINLTFSLHSPFHDQRSELMPINNHFPLEEVMTVLDEHIQQTKRKVYIAYILLRGINDSTKHAKAVADLLRERGSWEHLYHVNLIPYNSTDATSQSFVESDQNSINMFLRILKSKGIHVTVRTQFGSDINAACGQLYGSNGNI	23.12	gnl|BL_ORD_ID|2211|hsp_num:0	2386
NODE_7029_length_4305_cov_7.42282_7 # 4001 # 4303 # 1 # ID=7028_7;partial=01;start_type=GTG;rbs_motif=AGGA/GGAG/GAGG;rbs_spacer=11-12bp;gc_cont=0.284	NODE_7029_length_4305_cov_7.42282_7 	4001	4303	+	Strict	960	198.749	lsaC	95.05	3003112	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; pleuromutilin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGTCAACAATTAAAATTGAAAATCTTAGTTTCTCATATTATGGCTATGAAAAACCTATATTTGAAAATGTATCATTTTCATTTGATACGAACTGGAAAACAGGGTTGATAGGAAGAAATGGAATTGGAAAATCAACACTATTTAAGCTACTTCTAAACCAAGAAGTTTATAAGGGGAAAATCAGCAAAAGTGTTGACTTTATTAAATTCCCACCCAATTTAAGTGATACTTCAAAATTAGGGATTGATTTATATAAAGAACTAATATCAGATGAGGAAGAATGGAAATTATTTAGAGAACTT	VSTIKIENLSFSYYGYEKPIFENVSFSFDTNWKTGLIGRNGIGKSTLFKLLLNQEVYKGKISKSVDFIKFPPNLSDTSKLGIDLYKELISDEEEWKLFREL	MSTIKIENLTFSYYGYVKPVFENVSFSFDTNWKTGLIGRNGIGKSTLFKLLLNQEVYKGKISKSVDFIKFPPNLSDTSKLGIELYRELISDEEEWKLFRELHLLKVDESLIYRKFETLSKGEQTKILLAILFTREDGFLLIDEPTNHLDMDGRKIVSEYLKNKKGFLLISHDRDFLDGCINHIISINRNSIDVQSGNFTSWYENKLMKDQFEISQNEKLRKDIKRLKEAARQSQIWSDKVENTKNGVKVSGVKPDKGHIGHQSAKMMKKSKNLENRQNKAIEEKQNLLKDIETKESLLLHPLHHHKNPLISVCDLSSYYGKKQILSNISFDIKQGDIVAIYGGNGSGKSTLIKILLGLNHEYSGDVKLASNLKISYVPQDTSNLTGSLNEYIHKQGVDETLCKTILRKLDFARELFEIDMKNYSDGQKKKVLIAVSLSKSAHIFIWDEPLNYLDVISRIQIEEIIKEANPTLIFVEHDKSFVEDIANKIIRL	20.53	gnl|BL_ORD_ID|1669|hsp_num:0	1748
NODE_8013_length_3833_cov_2.65484_3 # 3767 # 3832 # 1 # ID=8009_3;partial=01;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.621	NODE_8013_length_3833_cov_2.65484_3 	3767	3832	+	Strict	700	18.8606	Escherichia coli ampC beta-lactamase	100.0	3004290	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ampC-type beta-lactamase	ATGACGTGCCGAACCCGCTCGTACTGCAATGAGACTTTCTCGCCGGTGTCACCGGGCGCGCTTGAC	MTCRTRSYCNETFSPVSPGALD	MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVDAAWQILNALQ	5.84	gnl|BL_ORD_ID|2342|hsp_num:0	2843
NODE_8411_length_3669_cov_27.0974_1 # 3 # 86 # 1 # ID=8405_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.607	NODE_8411_length_3669_cov_27.0974_1 	3	86	+	Strict	700	19.631	vanWI	100.0	3003724	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanW; glycopeptide resistance gene cluster	CGCGGCTTTGGCTTTGTGCACGGCGGCGTGGCGGATTCGGAACACGGCGGGGCAGAATGGCATGAGATGACGCTGCTGTTTTAA	RGFGFVHGGVADSEHGGAEWHEMTLLF	MLRRKPWVFLLVILFSQLSLSILLGATVTYGAGYAKAPEGLTVWEKDLGGMTKDEAYAVLAEVIPKAVVYDRTVYFLELNQTDQDLKDYLASQYIISTGNVITDAFEYLHRMSRTIPSPELLNQEEVLAQLRKFALDIDQPGKAAEAYYENGEIVIEEGSLGVRLDVDKSWEQLQQSIGMETVPLVTEVIVVHPTTAELEKVKDPLGDYTTYFNPSFHERVTNVRLAAEAINGLILPPGGEFSFNDTVGKREPERGYLPALMYMGNRVVTDDGGGICQDSTTLYQATKQARLEVLERYSHSLPVSYVPLGQDATVAYGALDFRFRNTTQGYLLLNAATGGNWIRVRIFGVADSEHPALDEPDGYPVKPREWSK	7.24	gnl|BL_ORD_ID|2107|hsp_num:0	2242
NODE_8776_length_3540_cov_52.1733_4 # 1475 # 1726 # 1 # ID=8769_4;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.365	NODE_8776_length_3540_cov_52.1733_4 	1475	1726	+	Loose	450	28.1054	lnuG	31.25	3004085	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	TTGGATGACTATCGCCGAGAAGATTATCATTATGAATTCATTTATTTTCCGATGGGGCGATTGCGTTATTTTTTAAATGGAGATGACCGTTGGTTAAAGGAAAAACAGTATTTCGGTCTGCCAAAGTTTAAAGAATGGTGGGACAAAGCCGCTTATGCCGAATATTATTTATCAGAATGTGAATATGAAGGCAGTTGTGGTCCGGGTTATCAACCCTTAAGTGAAGAAGAATGGAAAAAACAACAAAAATAA	LDDYRREDYHYEFIYFPMGRLRYFLNGDDRWLKEKQYFGLPKFKEWWDKAAYAEYYLSECEYEGSCGPGYQPLSEEEWKKQQK	MLKQKELMARVKELVQSDERISACMMYGSFTKGEGDQYSDIEYYVFLKDDTISTFDSAKWLNEVASYTLLYQNEYGTEVVIFENLIRGEFHFLSENEMNIIPSFKESGYIPDTKAMFIYDETGQLELYLSELEGPGPNRLTEENVNFLLNNFSNLWLMGINVLKRGENARSLELLSQLQKNILQLIRIAEENADNWFNMTKNLEKEISPENYEKFKKTTARLNELELYEAYKNSLLLVMELRNLVEKQYQLTISDDFLGKLFNYMNE	31.09	gnl|BL_ORD_ID|2300|hsp_num:0	2749
NODE_8782_length_3537_cov_5.56864_4 # 3211 # 3411 # -1 # ID=8775_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.264	NODE_8782_length_3537_cov_5.56864_4 	3211	3411	-	Loose	700	22.3274	CMY-85	26.19	3002098	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGAACACGGAATCACAATGGTATTTACTGGCATCAGACATTTCAAACATTAAAATTAAACAAATACTTGTTTTTATAGATAAACTGTACTTAAAATATATGAAAAGGGGTAACCTATATCAAAATTTAAGAATAGAGGGACAATTAAAATTCAAAAAACTATATAATCCCAATTATATAATGGGATATAGACCACCCTAA	MNTESQWYLLASDISNIKIKQILVFIDKLYLKYMKRGNLYQNLRIEGQLKFKKLYNPNYIMGYRPP	MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGALAVKSSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYLEGKPLHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQLGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ	17.32	gnl|BL_ORD_ID|264|hsp_num:0	283
NODE_9228_length_3389_cov_2.89682_1 # 3 # 92 # 1 # ID=9214_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.267	NODE_9228_length_3389_cov_2.89682_1 	3	92	+	Loose	450	21.1718	aadA9	31.03	3002609	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(3'')	AACTCTAATATTATAAAACAAAAAGAAAGGATAACAAATGAGTCAGATAATTTATGTAACTCCAAACTTCATACAGGAGTTAGAAGATGA	NSNIIKQKERITNESDNLCNSKLHTGVRR	MLWSSNDVTQQGSRPKTKLDMMSNSIHTGISRQLSQARDVIKRHLASTLKAIHLYGSAIDGGLKPYSDIDLLVTVDARLDEATRRSLMLDFLNISAPPCESSILRPLEVTVVACNEVVPWRYPARRELQFGEWLREDILEGVFEPAALDADLAILITKARQHSIALVGPVAQKVFMPVPEHDFLQVLSDTLKLWNTHEDWENEERNIVLTLARIWYSTETGGIVPKDVAAEWVLERLPAEHKPILVEARQAYLGLCKDSLALRADETSAFIGYAKSAVADLLEKRKSQTSHICDGAKNV	9.70	gnl|BL_ORD_ID|303|hsp_num:0	323
NODE_10103_length_3128_cov_30.9671_6 # 3027 # 3128 # 1 # ID=10078_6;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.500	NODE_10103_length_3128_cov_30.9671_6 	3027	3128	+	Loose	400	21.9422	Erm(39)	50.0	3000602	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAAATGGTTTTCCCGCCCCGCCGTTATCCTGAAAACGCTGTATCGCTATGGTTTGGCCGATATGGTTACGCCGCATATTCGCTTGCGCTGGTTGCAAAAA	MKWFSRPAVILKTLYRYGLADMVTPHIRLRWLQK	MSSVHHGRHENGQNFLRDRRVVGDIVRMVSHTAGPIVEIGAGDGALTLPLQRLGRPLTAIEIDLHRARRLADRTTAEVIATDFLRYRLPRTPHVVVGNLPFHLTTAILRRLLHENGWTDAILLVQWEVARRRAGVGGATMMTAQWWPWFEFGLARKVSADAFRPRPSVDAGLLTIQRRAEPLLPWADRRAYQALVHRVFTGRGRGLAQILRPHVHPRWLSANGIHPSALPRALTARQWVALFDAAG	13.82	gnl|BL_ORD_ID|1626|hsp_num:0	1701
NODE_10650_length_2970_cov_19.3355_4 # 2016 # 2405 # 1 # ID=10613_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.338	NODE_10650_length_2970_cov_19.3355_4 	2016	2405	+	Loose	1750	23.8682	amrB	37.04	3002983	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAGAAAGTAGCTTTCATTTGTGTCCATAATTCATGCAGAAGTCAGATTGCAGAAGCATTGGGAAAGCATTTTGCATCCGATGTATTTGAAAGTTATTCTGCCGGAACGGAAACAAAGCCACAAATCAATCAAGATGCAATTCGTATTATGAAAGAAATGTATGGTATTGATATGGAGAAAGCACAATATTCAAAGCTAATTTTGGATATACCAGAGCCAGATATTGTTATTTCTATGGGATGTAATGTTCAATGTCCTTTCATTGGAAGAGCATTTGATGATAACTGGGGATTGGATGATCCGACTGGAAAATCACATGAAGAATTCACTGAAATAATTAGCCAGATAGAACTTAAAATAAAGAATTTGATAGATAGAATGAAATAG	MKKVAFICVHNSCRSQIAEALGKHFASDVFESYSAGTETKPQINQDAIRIMKEMYGIDMEKAQYSKLILDIPEPDIVISMGCNVQCPFIGRAFDDNWGLDDPTGKSHEEFTEIISQIELKIKNLIDRMK	MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEESVTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKIVEARLPEPVRRDGISIEKAADNAQIIVSLTSEDGRLSGVELGEYASANVLQALRRVEGVGKVQFWGAEYAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLTTPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVATEKRVRATMEELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQNFRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMVEEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFSAFLALSLTPALCATLLKPVADDHHEKDGFFGWFNRFVARSTHRYTRRVGRVLERPLRWLVVYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSPSAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRARDQVQAIIAEINAHFAGTPNTMVFAINMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLAEGRKDPVLTDLMFAGTQDAPQLKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGRHRLDAADVTKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIERIASTLPAGTGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVPLGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEAARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFVCVGRVFDVVPRRRGGAQAALEAK	12.37	gnl|BL_ORD_ID|445|hsp_num:0	476
NODE_11023_length_2885_cov_2.31873_2 # 882 # 1013 # -1 # ID=10976_2;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.371	NODE_11023_length_2885_cov_2.31873_2 	882	1013	-	Loose	750	20.4014	mefE	52.94	3000614	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAACTCTTAATTTTTCAGTTGCCATCACTTACAGCCATTATTTGTGCATTTTTGCTGTTGAGCCAAGGTATTAGTGGTTGGGGATGGTTTTTATTTATTGCTTTTTGTGTATCTGCTTCTAGGGCATAG	MKLLIFQLPSLTAIICAFLLLSQGISGWGWFLFIAFCVSASRA	MKIDKKNEAFLIVSRGISRIGDIMFDFANNTFLAGLNPTSLSLVAVYQSLESVIGVLFNLFGGVIADSFKRKKIIIVANILCGIACIILSFISQEQWMVFAIVITNIILAFMSAFSGPSYKAFTKEIVKKDSISQLNSLLEITSTIIKVTIPMVAILLYKLLGIHGVLLLDGFSFLIAASLISFIVPVNDEVVTKDKMTIGGVLNDLKIGFKYIYSHKTIFMIIILSAFVNFFLAAYNLLLPYSNQMFGEISDGLYGVFLTAEAIGGFIGAILSGVINKTLSSKRLMVFLSCSGLMLMLSTPLYFLFQNFIILAFSPALFSLFISIFNIQFFSIVQREVDTEFLGRVFGIIFTVAILFMPVGSGFFSVVLNPNNTFNLFIIGVSITILSLIFSTLLKRYDKNS	10.67	gnl|BL_ORD_ID|1335|hsp_num:0	1401
NODE_11300_length_2821_cov_4.01085_1 # 2 # 76 # -1 # ID=11251_1;partial=10;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.373	NODE_11300_length_2821_cov_4.01085_1 	2	76	-	Loose	200	24.6386	blaI	69.23	3000160	protein homolog model	n/a	n/a	penam	antibiotic inactivation	blaZ beta-lactamase	GTGAAAGAAAATTGCAGAATCGATAAAAAACAGCATATAACCGATGCAGAATGGGAAGTAATGCGAGTTGTGTGG	VKENCRIDKKQHITDAEWEVMRVVW	MSNQTPSISEAEWEVMKVLWKKGPQTANQVISAIQEQTDWKPKTIRTLLDRLTKKKVVGVDKEQKIYVFFPLYSEEACKHAEAQSFVKRVYGGTVKPLLVQFLEEESLTKEELDELYAILDQKRKE	19.84	gnl|BL_ORD_ID|1309|hsp_num:0	1374
NODE_12639_length_2549_cov_93.2598_4 # 2440 # 2547 # -1 # ID=12557_4;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.509	NODE_12639_length_2549_cov_93.2598_4 	2440	2547	-	Loose	1900	20.4014	MexK	36.84	3003693	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATCCTGGACCACCTGCGGGAAGTGATCGAGAGTTGGTTCAATAACCCCCAAAAACTTGCCGACATTATCAACAACGCCCAGGACAGCGACGTAGACTTCGACGACTAG	ILDHLREVIESWFNNPQKLADIINNAQDSDVDFDD	MSFNLSAWALQNRQIVLYLMILLGAVGALSYSKLGQSEDPPFTFKAMVVQTNWPGASAEEVARQVTERIEKKLMETGDYDRIVSFSRPGVSQVTFMAREDIHSSEIPELWYQIRKKISDIRATLPQSIQGPFFNDEFGTTYGNIYALTGKGFDYAVMKDYADRLQLQLQRIRNVGKVELIGLQDEKIWIDLSNTKLATLGLPLAAVQKALEEQNAVASSGFFETASDRVQLRVSGRFDSVEEIRDFPIRVGDRTFRIGDVAEVRRGFNDPPAPRMRFMGEDAIGLAVAMKPGGDILVLGKALETEFARLQQSLPAGLELRKVSDQPAAVRTGVGEFIRVLAEALVIVLLVSFFSLGLRTGLVVALSIPLVLAMTFAAMHYFGIGLHKISLGALVLALGLLVDDAIIAVEMMAVKMEQGYDRLKAASFAWTSTAFPMLTGTLITAAGFLPIATAQSGTGEYTRSLFQVVTIALVVSWFAAVVFVPYLGAKLLPDLARLHAQKHGGSADGYDPYATAFYQRFRRLVEWCVRYRKTVIVLTLAAFVGALLLFRLVPQQFFPPSARLELLLDIKLAEGASLRSTGEEVQRLEKMLQGHDGIDNYVAYVGTGSPRFYLPLDQQLPAASFAQVVVLAKDLESREALRKWLIERMNEDFPHLRSRISRLENGPPVGYPVQFRVSGEDIPQVRELARKVADKMRENPHVVNVHLDWEEPSKVVYLSIDQERARALGVSTASLSQFLQSALTGSHVSFFREDNELIEILLRGTEQERRDLSLLPSLAVPTENGRSVALSQIATLEYGFEEGIIWHRNRLPTVTVRADIYDDSLPATLVAQIAPTLEPIRAELPDGYLLEVGGTVEDAAKGQSSVNAGVPLFIVVVLSLLMVQLRSFSRMAMVFLTAPLGLIGVTLFLLLFRQPFGFVAMLGTIALAGMIMRNSVILVDQIEQDISHGLDRWHAIIEATVRRFRPIVLTALAAVLAMIPLSRSVFFGPMAVAIMGGLIVATVLTLLFLPALYAAWFRVKKDEARA	3.41	gnl|BL_ORD_ID|2086|hsp_num:0	2206
NODE_12971_length_2493_cov_4.47826_3 # 1193 # 1318 # 1 # ID=12880_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.627	NODE_12971_length_2493_cov_4.47826_3 	1193	1318	+	Loose	1300	21.9422	vanTG	26.67	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGACACACTGGCATTACGTCCTGATTGCCTATGGGCTGTCCGCCCTGGCTCTGGTGCTGGAGCTTGTGCTGCTGGCCGGACGCCGCCGGCATGCGCGCCACTGCATGGAAGACGCCAACTCATGA	MTHWHYVLIAYGLSALALVLELVLLAGRRRHARHCMEDANS	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	5.76	gnl|BL_ORD_ID|1488|hsp_num:0	1561
NODE_15476_length_2117_cov_3.80019_1 # 2 # 112 # 1 # ID=15272_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.279	NODE_15476_length_2117_cov_3.80019_1 	2	112	+	Strict	650	20.0162	vanL	100.0	3002910	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	TTTGAGTTGATGAATATACCAGAATCAAAAGTTACTTTAAGATTTTGGATAGCAACACTTATATTTGGAATAATAGCATTAGGAACAATTAAGATGAGAGGGATACTATAA	FELMNIPESKVTLRFWIATLIFGIIALGTIKMRGIL	MMKLKKIAIIFGGQSSEYEVSLKSTVSVLETLSTCNFEIIKIGIDLGGKWYLTTSNNKDIEYDVWQTDPSLQEIIPCFNNRGFYNKTTNKYFRPDVLFPILHGGTGEDGTLQGVFELMNIPYVGCGVTPSAICMDKYLLHEFAQSVGVKSAPTLIIRTRNCKDEIDKFIEKNDFPIFVKPNEAGSSKGINKVNEPDKLEDALTEAFKYSKSVIIQKAIIGREIGCAVLGNEKLLVGECDEVSLNSDFFDYTEKYQMISAKVNIPASISVEFSNEMKKQAQLLYRLLGCSGLARIDFFLSDNNEILLNEINTLPGFTEHSRYPKMMEAVGVTYKEIITKLINLAEEKYYG	10.32	gnl|BL_ORD_ID|326|hsp_num:0	349
NODE_17008_length_1944_cov_7.46215_2 # 259 # 417 # 1 # ID=16720_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.220	NODE_17008_length_1944_cov_7.46215_2 	259	417	+	Loose	1900	21.1718	MexW	33.33	3003031	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; acridine dye; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAATGATAAATTTAGAATACATTTTGAAATAATTTACAAGAAGAGGAAAAGAAGATATTTTGAATATTATGAAAATGGGGAAATAAAAGGCTATTTGATATTCATGAAAATGAGGATATTAAGTGGTGAAGAAGAAAATATTTACTATAAAGAATAA	MNDKFRIHFEIIYKKRKRRYFEYYENGEIKGYLIFMKMRILSGEEENIYYKE	MAFTDPFIRRPVLASVVSLLIVLLGMQAFSKLVIREYPQMENALITVTTLYAGANAETIQGYITQPLQQSLASAEGIDYMTSVSRQNYSTISIYARIGANTDRLVTELLAKSNEVKSQLPPDAEDPVLQKEAADASALMYISFYSEQMNNPQITDYLSRVIQPKLATLPGIAEAEILGNQVFAMRLWLDPVKMAAFGVTAGEINQAVQQYNFLAAAGEVKGQLVVTSVNASTDLKSPQAFAAIPVKTDGDRRVLMGDVARVELGAASYDAISSFNGIPSVYIGIKGTPSANPLDVIKEVRAKMPELEEQLPPNLKVSIAYDATRFIQASIDEVVKTLGEAVLIVIVVVFLFLGAFRSVLIPVVTIPLSMIGVLFFMQAMGYSINLLTLLAMVLAIGLVVDDAIVVVENIHRHIEEGKPPFEAALEGAREIAVPVVSMTITLAAVYAPIGFLTGLTGALFKEFAFTLAGAVIISGIVALTLSPMMCSRLLRHEENPSGLAHRLDLIFEGLKQRYQRALHGTLDTRPVVLVFAVLVLALIPVLLMFTKKELAPEEDQGIVFLMTNSPQTANLDYLNRYTAEFEGIFRSFPEYYSAFQINGYNGVQAGIGGMLLKPWDEREKSQMELLHAVQAKLNEIPGVQIFAFNLPSLPGTGEGLPFQFVLNTANDYESLLQVAQRVKQRASESGKFAFLDLDLAFDKPELVVDIDREKAAQMGVSMQDLGVALASLLGEGEINRFTIDGRSYKVIAQVERPYRDNPGWLGSYYVKSRNGQLVALSTLIETHERARPRQLNQFQQLNSAIISGFPIVSMGEAIETVQQIAREEAPRGFAVDYAGASRQYVQEGSALLVTFGLALAIIFLVLAAQFESFRDPLVIMVTVPLSICGALIPLFLGVSSLNIYTQVGLVTLIGLISKHGILIVEFANQLRHEQGLGRREAIEQAAAIRLRPVLMTTAAMVLGVIPLILATGAGAVSRFDIGIVIATGMSVGTLFTLFVLPCIYTLVARPDAPPGVTQAANAH	5.11	gnl|BL_ORD_ID|2088|hsp_num:0	2208
NODE_17248_length_1919_cov_5.83745_3 # 1848 # 1919 # -1 # ID=16944_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.778	NODE_17248_length_1919_cov_5.83745_3 	1848	1919	-	Loose	700	19.2458	vanSO	60.0	3002941	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	GTTCGCTACCCGCCCGACGGCGAGTTGGCCGGCCGCGCCCGCCTGACCCGGGCCCGCCGGGACTGCGGCTGA	VRYPPDGELAGRARLTRARRDCG	MLAGVLLLAAVWVFLLRGRSTNFQFPALADFARVFDPSNFGPVVFVPAAILALGFLLVFGLVGGWILAGRMLAPLARITRAAREAGSGSLSYRIELEGRNDEFRELADAFDAMLARLEARDAAQQRFAANASHELRTPLAITQTLLDVARNDPNRDGGELDERLRAVNARAIELTEALLLLSRTDQRSFSREDVDLSLIAEEAAETLLPFAEKHGVSIETSGDIAPVIGSHALLLQLTTNLLHNAIVHNVPEHGSVQISTAIGSESVMLTVENTGDKLSPQLVSTLTEPFQRGTARTRGDDARVGLGLAIVKSITQAHDGSLTLSPRAAGGLSVAVRLPAAQRRP	6.67	gnl|BL_ORD_ID|434|hsp_num:0	465
NODE_17758_length_1871_cov_2.39758_2 # 1754 # 1870 # -1 # ID=17420_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.641	NODE_17758_length_1871_cov_2.39758_2 	1754	1870	-	Loose	125	22.7126	vanUG	47.62	3004253	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanU	AACCGTGGCGGAGGCCTTCTCATCTGTCGAAGGCTCCGTGTAGGCCAGACACGAGAAGCCGTCGATGACGGTGTGCAGGTAGGTGTGGCCGCCCCTGGCTCCCATACCCCGGCTTGA	NRGGGLLICRRLRVGQTREAVDDGVQVGVAAPGSHTPA	MRVSYNKLWKLLIDRDMKKGELREAVGVSKSTFAKLGKNENVSLTVLLAICEYLNCDFGDIIEALPETPDKERDS	50.67	gnl|BL_ORD_ID|932|hsp_num:0	943
NODE_19577_length_1724_cov_6.41522_2 # 681 # 1646 # 1 # ID=19103_2;partial=00;start_type=ATG;rbs_motif=TATAA;rbs_spacer=11bp;gc_cont=0.356	NODE_19577_length_1724_cov_6.41522_2	681	1646	+	Perfect	600	661.759	CfxA2	100.0	3003002	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	ATGGAAAAAAACAGAAAAAAACAAATCGTAGTTTTGAGTATAGCTTTAGTTTGCATTTTCATCTTGGTATTTTCATTGTTCCATAAATCAGCGACAAAAGATAGCGCAAATCCTCCTTTAACAAATGTTTTGACTGATAGCATTTCTCAAATTGTCTCAGCTTGTCCTGGCGAAATTGGTGTGGCGGTTATTGTTAATAACAGAGATACGGTTAAGGTCAATAATAAGAGTGTTTATCCTATGATGAGTGTGTTTAAGGTTCATCAGGCATTAGCTCTTTGTAATGACTTTGACAATAAAGGAATTTCACTTGATACCTTAGTAAATATAAATAGGGATAAACTTGACCCAAAGACTTGGAGTCCTATGCTGAAAGATTATTCAGGGCCAGTCATATCATTGACAGTGAGAGATTTGCTGCGTTATACTCTTACTCAGAGTGACAACAATGCAAGCAACCTTATGTTTAAGGATATGGTTAATGTCGCTCAAACAGATAGTTTTATAGCCACACTCATTCCTCGTTCAAGTTTTCAGATAGCTTATACGGAAGAGGAAATGTCGGCTGACCATAACAAGGCTTACTCTAACTATACATCTCCTCTTGGTGCTGCAATGTTGATGAATCGTTTGTTTACTGAAGGTCTTATCGATGATGAGAAACAAAGTTTCATTAAGAATACGTTAAAAGAATGCAAAACAGGTGTAGATAGGATAGCAGCTCCACTTCTTGATAAAGAAGGGGTTGTTATAGCGCATAAGACAGGTTCAGGTTATGTTAATGAAAATGGTGTTCTTGCAGCTCACAATGATGTTGCCTATATATGTCTGCCTAATAATATCAGTTATACCTTAGCGGTATTTGTTAAGGATTTCAAGGGAAATGAATCACAAGCGTCACAATATGTTGCGCATATATCAGCTGTAGTATATTCTTTATTAATGCAAACTTCAGTAAAATCTTAA	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	100.00	gnl|BL_ORD_ID|162|hsp_num:0	174
NODE_21569_length_1585_cov_15.0046_2 # 970 # 1305 # -1 # ID=20908_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.634	NODE_21569_length_1585_cov_15.0046_2 	970	1305	-	Loose	500	26.9498	APH(3'')-Ia	50.0	3002638	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3'')	ATGCGCCTCGCCACCCTCGCGCCACAGGGACGGATCACCACTGAACTGGTGCAGGCGGAAATCGCCCGCCTGCGCTGGCTGTGGCAGGACACGAGCGCCCCTGCCGCGAGCGTCATCCCCGCCAAAGCAAATCCCGACAGTCTTGACCTCTTTGACCGCCTGCAACTGGAAAACGTCATCACCGTCTGCCGTCAGCATAAAACCCTCGCTGCCGCCGGCCGCGCCCTCTACCACATCTCGCGCGAACAGCGCGCCACCGCCAACGACAGCGACCGCCTGCGCAAATACCTGCACAAATTCGGCTTAACTTGGGCGGATATCACGGCGTCTTCGTGA	MRLATLAPQGRITTELVQAEIARLRWLWQDTSAPAASVIPAKANPDSLDLFDRLQLENVITVCRQHKTLAAAGRALYHISREQRATANDSDRLRKYLHKFGLTWADITASS	MSDHPGPGAVTPELFGVGGDWLAVTAGESGASVFRAADATRYAKCVPAADAAGLEAERDRIAWLSGQGVPGPRVLDWYAGDAGACLVTRAVPGVPADRVGADDLRTAWGAVADAVRRLHEVPVASCPFRRGLDSVVDAARDVVARGAVHPEFLPVEQRLVPPAELLARLTGELARRRDQEAADTVVCHGDLCLPNIVLHPETLEVSGFIDLGRLGAADRHADLALLLANARETWVDEERARFADAAFAERYGIAPDPERLRFYLHLDPLTWG	40.81	gnl|BL_ORD_ID|1839|hsp_num:0	1923
NODE_21709_length_1576_cov_3.09402_2 # 1442 # 1576 # 1 # ID=21034_2;partial=01;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.696	NODE_21709_length_1576_cov_3.09402_2 	1442	1576	+	Loose	500	21.1718	APH(3')-IVa	50.0	3002648	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGACCCACACCGCACCCACCCGCCCCGACTTCGCCTGGCTTACCGAAGACAGCCGCCTCTTCCTCCAGCGCGGCTACCTCCTGGACGGCACCACCCCAGAAGCGCGCATCCGTGCCATCGCCGAACACGCCGGC	MTHTAPTRPDFAWLTEDSRLFLQRGYLLDGTTPEARIRAIAEHAG	MNESTRNWPEELLELLGQTELTVNKIGYSGDHVYHVKEYRGTPAFLKIAPSVWWRTLRPEIEALAWLDGKLPVPKILYTAEHGGMDYLLMEALGGKDGSHETIQAKRKLFVKLYAEGLRSVHGLDIRECPLSNGLEKKLRDAKRIVDESLVDPADIKEEYDCTPEELYGLLLESKPVTEDLVFAHGDYCAPNLIIDGEKLSGFIDLGRAGVADRYQDISLAIRSLRHDYGDDRYKALFLELYGLDGLDEDKVRYYIRLDEFF	17.18	gnl|BL_ORD_ID|1204|hsp_num:0	1260
NODE_21955_length_1559_cov_6.00266_2 # 1447 # 1557 # -1 # ID=21257_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.432	NODE_21955_length_1559_cov_6.00266_2 	1447	1557	-	Loose	725	20.7866	mdtA	47.83	3000792	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTTGACGACTGGAAGGAGGAGTTTCGGAGTTGGGCAAATAAAAGTCGTAGTCTAGCCATAGGTGCAGGATTTGCGGCAATGAGCAATCCTGCGAAAAAAAGAAAAAACTAA	FDDWKEEFRSWANKSRSLAIGAGFAAMSNPAKKRKN	MKGSYKSRWVIVIVVVIAAIAAFWFWQGRNDSRSAAPGATKQAQQSPAGGRRGMRSGPLAPVQAATAVEQAVPRYLTGLGTITAANTVTVRSRVDGQLIALHFQEGQQVKAGDLLAEIDPSQFKVALAQAQGQLAKDKATLANARRDLARYQQLAKTNLVSRQELDAQQALVSETEGTIKADEASVASAQLQLDWSRITAPVDGRVGLKQVDVGNQISSGDTTGIVVITQTHPIDLVFTLPESDIATVVQAQKAGKPLVVEAWDRTNSKKLSEGTLLSLDNQIDATTGTIKVKARFNNQDDALFPNQFVNARMLVDTEQNAVVIPTAALQMGNEGHFVWVLNSENKVSKHLVTPGIQDSQKVVIRAGISAGDRVVTDGIDRLTEGAKVEVVEAQSATTPEEKATSREYAKKGARS	8.67	gnl|BL_ORD_ID|362|hsp_num:0	387
NODE_24652_length_1398_cov_5.03872_2 # 428 # 1396 # -1 # ID=23633_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.397	NODE_24652_length_1398_cov_5.03872_2 	428	1396	-	Strict	1200	651.358	tetQ	96.27	3000191	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GATATAGAAGATTTTCGAATCGGAGATTATTTAGGTGCTAAACCTTGTTTGATTCAAGGATTATCTCATCAGCATCCCGCTCTCAAATCCTCCGTCCGGCCAAATAAGCCCGAAGAGAGAAGCAAGGTGATATCCGCTCTGAATACATTGTGGATTGAAGACCCGTCTTTGTCCTTTTCCATAAACTCATATAGTGATGAATTGGAAATCTCGTTATATGGTTTGACCCAAAAGGAAATCATACAGACATTGCTGGAAGAACGATTTTCCGTAAAGGTCCATTTTGATGAGATCAAGACTATCTACAAAGAACGACCTATAAAAAAGGTCAATAAGATTATTCAGATCGAAGTACCACCCAACCCTTACTGGGCCACAATAGGGCTGACTCTTGAACCCTTACCGTTAGGGGCAGGGTTGCAAATCGAAAGTGACATCTCCTATGGTTATCTGAACCATTCTTTTCAAAATGCCGTTTTTGAAGGGATTCGTATGTCTTGCCAATCTGGTTTACATGGATGGGAAGTGACTGATCTGAAAGTAACTTTTACTCAAGCCGAGTATTATAGCCCGGTAAGTACACCTGCTGATTTCAGACAGCTGACCCCTTATGTCTTCAGGCTGGCCTTGCAACAGTCAGGTGTGGACATCCTCGAACCGATGCTCTATTTTGAGTTGCAGATACCCCAATCGGCAAGTTCCAAAGCTATTACAGATTTGCAAAAAATGATGTCTGAGATTGAAGACATCAGTTGCAATAATGAGTGGTGTCATATTAAAGGGAAAGTTCCATTAAATACAAGTAAAGACTATGCCTCAGAAGTAAGTTCGTACACTAAGGGCTTAGGCATTTTTATGGTTAAGCCATGTGGGTATCAAATAACAAAAGACGGTTATTCTGATAATATCCGCATGAACGAAAAAGATAAACTTTTATTCATGTTCCAAAAATCAATGTCATTAAAATAA	DIEDFRIGDYLGAKPCLIQGLSHQHPALKSSVRPNKPEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQSASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGIFMVKPCGYQITKDGYSDNIRMNEKDKLLFMFQKSMSLK	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	49.01	gnl|BL_ORD_ID|1133|hsp_num:0	1183
NODE_25336_length_1363_cov_159.297_1 # 1254 # 1361 # -1 # ID=24214_1;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.509	NODE_25336_length_1363_cov_159.297_1 	1254	1361	-	Loose	1900	20.4014	MexK	36.84	3003693	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATCCTGGACCACCTGCGGGAAGTGATCGAGAGTTGGTTCAATAACCCCCAAAAGCTTGCCGACATTATCAACAACGCCCAGGACAGCGACGTAGATTTCGACGACTAG	ILDHLREVIESWFNNPQKLADIINNAQDSDVDFDD	MSFNLSAWALQNRQIVLYLMILLGAVGALSYSKLGQSEDPPFTFKAMVVQTNWPGASAEEVARQVTERIEKKLMETGDYDRIVSFSRPGVSQVTFMAREDIHSSEIPELWYQIRKKISDIRATLPQSIQGPFFNDEFGTTYGNIYALTGKGFDYAVMKDYADRLQLQLQRIRNVGKVELIGLQDEKIWIDLSNTKLATLGLPLAAVQKALEEQNAVASSGFFETASDRVQLRVSGRFDSVEEIRDFPIRVGDRTFRIGDVAEVRRGFNDPPAPRMRFMGEDAIGLAVAMKPGGDILVLGKALETEFARLQQSLPAGLELRKVSDQPAAVRTGVGEFIRVLAEALVIVLLVSFFSLGLRTGLVVALSIPLVLAMTFAAMHYFGIGLHKISLGALVLALGLLVDDAIIAVEMMAVKMEQGYDRLKAASFAWTSTAFPMLTGTLITAAGFLPIATAQSGTGEYTRSLFQVVTIALVVSWFAAVVFVPYLGAKLLPDLARLHAQKHGGSADGYDPYATAFYQRFRRLVEWCVRYRKTVIVLTLAAFVGALLLFRLVPQQFFPPSARLELLLDIKLAEGASLRSTGEEVQRLEKMLQGHDGIDNYVAYVGTGSPRFYLPLDQQLPAASFAQVVVLAKDLESREALRKWLIERMNEDFPHLRSRISRLENGPPVGYPVQFRVSGEDIPQVRELARKVADKMRENPHVVNVHLDWEEPSKVVYLSIDQERARALGVSTASLSQFLQSALTGSHVSFFREDNELIEILLRGTEQERRDLSLLPSLAVPTENGRSVALSQIATLEYGFEEGIIWHRNRLPTVTVRADIYDDSLPATLVAQIAPTLEPIRAELPDGYLLEVGGTVEDAAKGQSSVNAGVPLFIVVVLSLLMVQLRSFSRMAMVFLTAPLGLIGVTLFLLLFRQPFGFVAMLGTIALAGMIMRNSVILVDQIEQDISHGLDRWHAIIEATVRRFRPIVLTALAAVLAMIPLSRSVFFGPMAVAIMGGLIVATVLTLLFLPALYAAWFRVKKDEARA	3.41	gnl|BL_ORD_ID|2086|hsp_num:0	2206
NODE_25485_length_1355_cov_8.57462_3 # 1260 # 1355 # -1 # ID=24340_3;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.427	NODE_25485_length_1355_cov_8.57462_3 	1260	1355	-	Strict	1700	20.0162	AxyY	100.0	3004144	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTTTTTGACGGTGCGGTCGGCGGTAAAAATAGCGAAGTCTCGCTACCGCTTGAGCTCGTAAAAGAGAATTTAAAGCAAAATTTCGGGTTGTTTTAG	FFDGAVGGKNSEVSLPLELVKENLKQNFGLF	MARFFIDRPVFAWVISLLIALVGLLSIRALPVAQYPDIAPPVVNIGASYPGASAKVVEEAVTAIIEREMNGAPGLMYTSSSSDSTGWASINLTFKQGTNPDIAAVEVQNRLKAVEPRLPESVRRDGVRVEKAADNIQLVVSLKSDGSLDDMQLGELAASNVLQALRRVEGVGKVQSFGAEAAMRIWPDPAKLTALSLTPGDIVSALRSHNARVTIGELGNQAVPKDAPLNASIVAGESLHTPEQFANIPLRALPDGATLRLKDVARVELGGTDYMYLSRVNGLTGTGLGIKLAPGSNAVETTRRIRETMRELAQYFPPGVTWDIPYETSTFVEISIKKVLMTLLEAVALVFCVMYLFMQNLRATLIPTLVVPVALLGTLGVMLGLGYSINVLTMFGMVLAIGILVDDAIVVVENVERIMAEEGLSPHDATVKAMGQISGAIVGITVVLVSVFVPMAFFDGAVGNIYRQFAVTLAVSIAFSAFLALSLTPALCASLLKPVPAGHHEKRGFFGWFNRAFARLTTRYTARVAGVLARPVRFGLAYALVIGVAALLFARLPSSFLPDEDQGSFMAMVILPQGSPQAETMAVVKDVERYMMEHEPVQYVYSVNGFSQYGSGPNSAMFFVTLKDWKERRDASQHVDAVVKRINKAFADRKNLMVFALNSPPLPDLGSTSGFDFRLQDRGGLGYEALTQARQKLLAKAAEHPALTDVVFAGQEEAPQLQLRVDRDKAQAMGVPIDEINTALAVMYGSDYIGDFMLNGQVRRVMVQADGKRRVDVDDISRLHVRNLQGQMVPLSAFATLTWSMGPPQLNRYNGFPSFTINGSAARGHSSGEAMRAMETLAAELPRGIGFDWSGQSYEERLSGNQAPVLFALSVLIVFLALAALYESWSIPLAVILVVPLGVIGALLGVTVRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVRDGQGILSATLEAARLRLRPIVMTSLAFGVGVLPLALATGAASGAQAAIGTGVLGGIITATVLAVFLVPLFFLIVGRMVGMRARPARPDGREPLETTP	2.97	gnl|BL_ORD_ID|2324|hsp_num:0	2799
NODE_28018_length_1244_cov_2.05719_3 # 1089 # 1244 # 1 # ID=26493_3;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.609	NODE_28018_length_1244_cov_2.05719_3 	1089	1244	+	Loose	500	21.557	NDM-10	32.0	3002360	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NDM beta-lactamase	ATGCTCTGCTTCCGTTTCCATGATATTCCAGGCCTGGTCCGGCTTTGCGTCGTGAGAGAGGGGCGTCGTGGTGATGTGGCATGGCACCCGGTCTCGGTGCATGTCTGGCAGGAGGCCTTGAGGTTCTCGACGCCGTCCTGCTTCAGGAGTCAGGAG	MLCFRFHDIPGLVRLCVVREGRRGDVAWHPVSVHVWQEALRFSTPSCFRSQE	MELPNIMHPVAKLSTALAAALMLSGCMPGEISPTIDQQMETGDQRFGDLVFRQLAPNVWQHTSYLDMPSFGAVTSNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGIDRTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAITHTARMADKLR	19.26	gnl|BL_ORD_ID|60|hsp_num:0	70
NODE_28421_length_1228_cov_24.7178_2 # 699 # 1226 # 1 # ID=26840_2;partial=01;start_type=ATG;rbs_motif=AATAA;rbs_spacer=13bp;gc_cont=0.358	NODE_28421_length_1228_cov_24.7178_2 	699	1226	+	Loose	550	30.8018	PmrF	23.86	3003578	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGCATGCTGAAAAATCAATTTGTGCAGTGGTTGTGACGTTTAACCGCAAGGCATTATTATTAAATTGCTTAAATGCACTGAAAGCTCAAACCCACTCTTTATCTCATATTGTGGTGATTGATAATGCCAGTACTGATGGTACAGCCGATTTTTTAGGTGAGCATGGTTGGACAAATAATGATGCTTTTACTTTGATTACCTTGCCCGAAAATATGGGAGGGGCAGGTGGATTCCATGAGGGAATCAAGTATGCGTTTGAACAAGGTTTTGATTATATTTGGTTAATGGATGATGATGGATTTCCAGCTGAAACATGTTTGGAAAAACTCTTACCTTACACAACTGAGAATTGTTATATAGGTCCGATAGTGATTGATTGTGGAGGCAAAGATAAACTAAGTTTTAGCTTACGTTTACCAAATAGTTTGCAAGTACTCGATCATTACTCTGATATTCCTCAGTCTTTAAAAATAGATAATCAAATTAAGGATACAGTATTGCCTTTTAATGGTACATTAATCGGAAGA	MHAEKSICAVVVTFNRKALLLNCLNALKAQTHSLSHIVVIDNASTDGTADFLGEHGWTNNDAFTLITLPENMGGAGGFHEGIKYAFEQGFDYIWLMDDDGFPAETCLEKLLPYTTENCYIGPIVIDCGGKDKLSFSLRLPNSLQVLDHYSDIPQSLKIDNQIKDTVLPFNGTLIGR	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	54.66	gnl|BL_ORD_ID|2003|hsp_num:0	2014
NODE_29424_length_1191_cov_2.98768_1 # 3 # 257 # 1 # ID=27666_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.537	NODE_29424_length_1191_cov_2.98768_1 	3	257	+	Strict	1100	21.9422	tetB(60)	100.0	3004036	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	AGCTACACCCGCTACCTCACGCAAACCTTCCGCAAAGCCTTCAACCTGCAAGGCACGCCGCTGCGGATTCAGTACAACGTGGGCGAAAATCCGTATGAGGAAACCGCCGAGAAAACCAAAAACAAACCCCTGCGCCGCGCCACGCTGAGCAACCGCATCGCCAAACGTGAAAACCGCAAAGAAGAAAAAGTACGCAACAGCGGCGGCAAGAAGAAACAGCGGCAAGTGAGCGTGAAGAAGAAAATGGCCAAATAA	SYTRYLTQTFRKAFNLQGTPLRIQYNVGENPYEETAEKTKNKPLRRATLSNRIAKRENRKEEKVRNSGGKKKQRQVSVKKKMAK	MRTMKRLLSYLRYEKKGVLIGLFCLLLSTGATLTGPLVAKHIIDNVITPMGQAHDFKAGGLLLWVGIYVTVNLVGVAGAYLNRVYMKTLSNRIAKRIRDEVFEHVQTLPVSYFDHLPAGKVVSRITSDTESVRANFYVSGISTLFSTIVMLVGVYITIFLLNATLGLVLLFLVPVMILWQRTVATKQKKYYSENRELYSQLSGQLNESIQGAGIVQAFQQEEKIVAEYDATATSWVEVGRKELILESYFSWSLVGMLRNITHFGVIYYFSMQFIGGTLGISAGLLYAFIDYINRIYEPIQTFMNVVSGFQQSMAAGDRVFELMDTPSEESGEELFTFDEGCIEFKDVSFEYTAGVPVLKHLNFTVEPGQTVAFVGHTGSGKSSIMNLLFRFYDPTSGAIFIDGKNTRDFNRRSVRSEMGIVLQDPYLFTGTIASNVGLNNESIEPETIKEAIIKVGGGHLLTKSDKGLDYEVKEKGMDFSSGERQLISFARAIVFDPKILILDEATSHIDTETEEIIQNAINVVKEGRTTFMIAHRLSTIAHADQIFVLDKGEIVERGTHDELLQLQGQYAEMVALQKG	14.51	gnl|BL_ORD_ID|2252|hsp_num:0	2646
NODE_30216_length_1162_cov_2.77236_1 # 1 # 120 # -1 # ID=28306_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.625	NODE_30216_length_1162_cov_2.77236_1 	1	120	-	Strict	500	82.8037	sul2	100.0	3000412	protein homolog model	n/a	n/a	sulfonamide antibiotic; sulfone antibiotic	antibiotic target replacement	sulfonamide resistant sul	ATGCATTCGGTGCAAGACGGGCAGGCAGATCGGCGCGAGGCACCCGCTGGCGACATCATGGATCACATTGCGGCGTTCTTTGACGCGCGCATCGCGGCGCTGACGGGTGCCGGTATCAAA	MHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIK	MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVSSDTEIARIAPVLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAKSSAKLVVMHSVQDGQADRREAPAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRLRFDLPVLLSVSRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAALKETARIR	14.76	gnl|BL_ORD_ID|910|hsp_num:0	952
NODE_31656_length_1113_cov_9.92344_1 # 3 # 119 # -1 # ID=29508_1;partial=10;start_type=ATG;rbs_motif=AAAA;rbs_spacer=15bp;gc_cont=0.368	NODE_31656_length_1113_cov_9.92344_1 	3	119	-	Strict	1900	20.7866	mexN	100.0	3003705	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAGATTATCAGTTATAATGTAAATGGCATTCGTGCTGCTCTTACTAAAGGTTTTGCAGAGTGGTTGAAAAGTGCTAACCCCGATGTGCTTTGTTTGCAAGAGATTAAGGCTTTA	MKIISYNVNGIRAALTKGFAEWLKSANPDVLCLQEIKAL	MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSPETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAAGRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIFVVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLFNASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEAGASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVVASLTLAPMLASRFMPALRHAEAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVAVAGYVGIPKGFFPLQDTAFVIGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVGVTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGPSRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARFGLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEMVPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTIIGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFLLWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMSAEQAIYQACLTRFRPIMMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHRRGTTTSDGGTAGATAT	3.76	gnl|BL_ORD_ID|2091|hsp_num:0	2217
NODE_32857_length_1075_cov_2.89804_3 # 1012 # 1074 # 1 # ID=30461_3;partial=01;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.492	NODE_32857_length_1075_cov_2.89804_3 	1012	1074	+	Loose	890	19.2458	cpxA	85.71	3000830	protein homolog model	n/a	n/a	aminoglycoside antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTAAAAAAAACATACACCGCAGTCTTCCACCCGGAAGTGGAAGCCGGCGGCTACTCAATC	MLKKTYTAVFHPEVEAGGYSI	MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTTEGRVIGAERSEMQIIRNFIGQADNADHPQKKKYGRVELVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSTPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTSQQRLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAQRLDSMINDLLVMSRNQQKNALVSETIKANQLWSEVLDNAAFEAEQMGKSLTVNFPPGPWPLYGNPNALESALENIVRNALRYSHTKIEVGFAVDKDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVETAIQQHRGWVKAEDSPLGGLRLVIWLPLYKRS	4.60	gnl|BL_ORD_ID|137|hsp_num:0	152
NODE_33847_length_1047_cov_3.15827_1 # 1 # 147 # -1 # ID=31246_1;partial=10;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=3-4bp;gc_cont=0.245	NODE_33847_length_1047_cov_3.15827_1 	1	147	-	Loose	700	22.7126	vanSD	40.91	3002934	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGAAAAAAAAAGAATTAAAAATTAATCCAGTACCACAAGACAGTAAATTTTACAATATCTATGCTCATATCTTATTATTATGGCCTTTTACTCCATTTATTTTTGCTGCTATTTATTTGTTTTTTGTTGGAGATGAAATTCGTTCA	MKKKELKINPVPQDSKFYNIYAHILLLWPFTPFIFAAIYLFFVGDEIRS	MKNRNKTSHEDDYLLFKNRLSVKILLMMACSILIIAGVYLFILKDNFANVVVAILDSFIYHDRDEAVVVYLRTFKAYEIWLFLIAVMGVFFMIFRRYLDSISKYFKEINRGIDTLVNEDANDITLPPELASTERKINSIRHTLTKRKTDAELAEQRKNDLVMYLAHDLKTPLSSVIGYLNLLRDENQISEELREKYLSISLDKAERLEELINEFFEITRLIFQISRLCTAKSI	21.03	gnl|BL_ORD_ID|2105|hsp_num:0	2139
NODE_34081_length_1041_cov_3.56085_2 # 814 # 1041 # -1 # ID=31417_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.693	NODE_34081_length_1041_cov_3.56085_2 	814	1041	-	Strict	600	22.3274	tet(A)	100.0	3000165	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	AAGGCGGCCGGCGGGCAGGGCATCGAGGTGGTCTCGGGCGGCCATGCACCGGCGGACGTTCAGCGTTTTGCGGGCTGGGCTCGCCGGCTGGAGCTGGCCGCGTCACGCGCCTCGGATTTTCACGATCCTGTCGAGAGCCGCTTCGATGTGGGCCAGGTGCCGCCATTGCCGCCCGATCTCACGCCGATCTGGGACGGCTGGTCGGAGCTGGCGGATATCCGCGCCTGA	KAAGGQGIEVVSGGHAPADVQRFAGWARRLELAASRASDFHDPVESRFDVGQVPPLPPDLTPIWDGWSELADIRA	MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPWLGKMSDRFGRRPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIADTTSASQRVKWFGWLGASFGLGLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFRETKNTRDNTDTEVGVETQSNSVYITLFKTMPILLIIYFSAQLIGQIPATVWVLFTENRFGWNSMMVGFSLAGLGLLHSVFQAFVAGRIATKWGEKTAVLLGFIADSSAFAFLAFISEGWLVFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVSLTNATGVIGPLLFAVIYNHSLPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA	18.70	gnl|BL_ORD_ID|1858|hsp_num:0	1808
NODE_35148_length_1013_cov_2.96033_1 # 3 # 185 # -1 # ID=32238_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.503	NODE_35148_length_1013_cov_2.96033_1 	3	185	-	Loose	750	21.557	mefC	35.14	3003745	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCGGTTTTATCTGCTTTATCTTTTCTTCCTGCCTCCTGGACATGGCAGTTTCTCGCCTTGGCGGTGTTGTGCAGTGTGGCGGTTTCTGTGTTGCTGAAAATAGCGCGCAAACAAGGAATTCACATTGAACACGCAATTGCGGTGAACTATATTGTGGCCACGGCCTGCTGCTGGCTGCTG	MPVLSALSFLPASWTWQFLALAVLCSVAVSVLLKIARKQGIHIEHAIAVNYIVATACCWLL	MENRKWFKTYMFIWAGQFASMLTSYAVQFAIVIWLSLEYKSAEVLAYAGIAAMLPQALIGLIAGVYVDRLNRKYVMIFSDAFIALCALLLLVILQNENVNLIWIYILLGLRSVGNAFHAPALQAIAPLIVPQNELIKVAGINQVLHSVCRIGGPAIGTLAIAYLPISKVLYLDLIGALLAILSLVMVKIPNVVAKSKSSAHSIATEFSEGFQTVSKNKGLRYLFLYAMAITFVIMPAAIMFPLLTTGHFAGGKWEIGIVEVVWGGGMLIGGVILSIFKLKGSKVVAVNVMYVLLGLTFILSGVLPASWFVGFVMVTAIGGISLSVFNGCFTAIVQTEVSPEKLGRVFSLYYSLAVLPSVIGLLFTGLIAEVIGVNITFIISGCLAILVGILSFSTRNLMQLGKIKNI	14.99	gnl|BL_ORD_ID|2123|hsp_num:0	2262
NODE_35166_length_1012_cov_2.05956_2 # 706 # 1011 # 1 # ID=32255_2;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.565	NODE_35166_length_1012_cov_2.05956_2 	706	1011	+	Loose	300	100.138	dfrA3	49.51	3003105	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGCTACTCTCTATAGTCGTGGCTGTGGCCAAGGATGGAGCTATAGGCAAGGGGAATGACTTGCTCTGGCACCTGCCTGGAGACCTCAAGCGCTTCAAGGCGCTCACTACAGGGCATACGATCCTGATGGGACGTAAGACCTTTGAGTCCCTGCCCAATGGTTCCTTGCCTCAGCGACGCAATGTCGTAATCAGCCGTTCACTTCAGAGCTCCGATGGGGTAGAGGTCTTCGCCTCGATCGACGAAGCCCTAGAGACCCTCTCCGAGAGCGACGACGAAGTCTTCGTCATCGGCGGTGGTGAGATC	MLLSIVVAVAKDGAIGKGNDLLWHLPGDLKRFKALTTGHTILMGRKTFESLPNGSLPQRRNVVISRSLQSSDGVEVFASIDEALETLSESDDEVFVIGGGEI	MLISLIAALAHNNLIGKDNLIPWHLPADLRHFKAVTLGKPVVMGRRTFESIGRPLPGRRNVVVSRNPQWQAEGVEVAPSLDAALALLTDCEEAMIIGGGQLYAEALPRADRLYLTYIDAQLNGDTHFPDYLSLGWQELERSTHPADDKNSYACEFVTLSRQR	62.96	gnl|BL_ORD_ID|484|hsp_num:0	511
NODE_35254_length_1010_cov_3.77696_1 # 1 # 75 # -1 # ID=32328_1;partial=10;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.800	NODE_35254_length_1010_cov_3.77696_1 	1	75	-	Strict	600	21.1718	MSI-1	100.0	3003718	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MSI beta-lactamase	ATGGGCACTCACGGGATCCCCTCAGCGCCGCCCGGCCGCCGCAGCGGCCCGGGGCTGCTCGTCGTGGCCGGTGCG	MGTHGIPSAPPGRRSGPGLLVVAGA	MGARSCSRAWCCSRATRSAPPGRRSGRLSCARCRRPSTGCNPSSTPPITGDIMKHIRLACVAAGLVAAASSVSAIGADWNAPQEPFALFGNSYYVGPHGVASVLITSNQGHILIDGGSDKSPPQIAARIRQLGFKPEDIRFILVSHEHIDHAGGVAELQRLSNAEVLAGAAAVPVLHSGEAGRNDPQYGGLPKMAPVARVRAVRDGEVVKLGPLAVTMHATPGHTQGGASWTWQSNEGGRTANMVYADSLTAFGSGGFRYSGDARYPSARADVERSIAKVAALPCDILVSAHPEVSELWTRYERRAAQGNAAFIDAGACKAYAVKARVKLQEQLARETAKP	7.33	gnl|BL_ORD_ID|2102|hsp_num:0	2233
NODE_35642_length_1001_cov_66.8182_2 # 924 # 1001 # -1 # ID=32629_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.538	NODE_35642_length_1001_cov_66.8182_2 	924	1001	-	Strict	230	19.631	marA	100.0	3000263	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan; penem	antibiotic efflux; reduced permeability to antibiotic	resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams	CCCGCCCCGACCAATCTGGTTGTTCCTCCCCATAAATACCTAAGCGACACCACCATCCAGGTCGGCGACGAAACATAA	PAPTNLVVPPHKYLSDTTIQVGDET	MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRSRKMTEIAQKLKESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMQGESRFLHPLNHYNS	19.69	gnl|BL_ORD_ID|1838|hsp_num:0	1922
NODE_36187_length_986_cov_4.11063_1 # 3 # 986 # 1 # ID=33047_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.398	NODE_36187_length_986_cov_4.11063_1 	3	986	+	Strict	1200	671.774	tetQ	99.09	3000191	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GAAAAGTGCGGCCGTGTGGATAATGGTGACACCATAACGGACTCTATGGATATAGAGAAACGTAGAGGAATTACTGTCCGGGCTTCTACGACATCTATTATCTGGAATGGAGTGAAATGCAATATCATTGACACTCCGGGACACATGGATTTTATTGCGGAAGTGGAGCGGACATTCAAAATGCTTGATGGAGCAGTCCTCATCTTATCCGCAAAGGAAGGCATACAAGCGCAAACAAAGTTGCTGTTCAATACTTTACAAAAACTGCAAATCCCGACAATTATATTTATCAATAAAATTGACCGTGACGGTGTGAATTTAGAGCGTTTGTATCTGGATATAAAAACAAATCTGTCTCAAGATGTCCTGTTTATGCAAACTGTTGTCGATGGATTGGTTTATCCGATTTGCTCCCAAACATATATAAAGGAAGAATACAAAGAATTTGTATGCAACCATGACGACAATATATTAGAACGATATTTGGCGGATAGCGAAATTTCACCGGCTGATTATTGGAATACGATAATCGCTCTTGTGGCAAAAGCCAAAGTCTATCCGGTGCTACATGGATCAGCAATGTTCAATATCGGTATCAATGAGTTGTTGGACGCCATTTCTTCTTTTATACTTCCTCCGGCATCAGTCTCAAACAGACTTTCAGCTTATCTCTATAAGATAGAGCATGACCCCAAAGGGCATAAAAGAAGTTTTCTTAAAATAATTGACGGAAGTCTGAGACTTCGAGACGTTGTAAGAATCAACGATTCGGAAAAATTCATCAAGATTAAAAATCTAAAGACTATTTATCAGGGCAGAGAGATAAATGTTGATGAAGTGGGGGCCAATGATATCGCGATTGTAGAAGATATGGAAGATTTTCGAATCGGAGATTATTTAGGTACTAAACCTTGTTTGATTCAAGGGTTATCTCATCAGCATCCCGCTCTCAAATCCTCCGTCCGGCCAGACAGGTCCGAAGAG	EKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIALVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPASVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDVVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEE	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	49.92	gnl|BL_ORD_ID|1133|hsp_num:0	1183
NODE_40713_length_887_cov_3.14663_1 # 802 # 885 # -1 # ID=36449_1;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.476	NODE_40713_length_887_cov_3.14663_1 	802	885	-	Strict	500	19.631	APH(6)-Id	100.0	3002660	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	GCCACTCTAGACACCATCGCGGTGAACCACAGCCACGATGCACATTGGCATGTGTCGATGATGAATAAAGTCCAAAACACCTGA	ATLDTIAVNHSHDAHWHVSMMNKVQNT	MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLVWRNGRGAVRLLGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRFAALFQRARDDQNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFGAANMFYDPADRDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEQEQRDLAIAAAIKQVRQTSY	9.71	gnl|BL_ORD_ID|989|hsp_num:0	1031
NODE_41847_length_866_cov_72.2367_3 # 786 # 866 # 1 # ID=37281_3;partial=01;start_type=ATG;rbs_motif=TAAAAA;rbs_spacer=11bp;gc_cont=0.420	NODE_41847_length_866_cov_72.2367_3 	786	866	+	Loose	700	20.0162	ADC-20	42.31	3003864	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamase	ATGCATATAGCCGTCATCTTCGAATTGTATAGTGGATTAAATTTAAATCAGGACAAGGCGACGAAGCCGCAGACAGTACAG	MHIAVIFELYSGLNLNQDKATKPQTVQ	MRFKKISCLLLSPLFIFSTSIYADNTPKDQEIKKLVDQNFKPLLDKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKTVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTSGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLKFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	7.05	gnl|BL_ORD_ID|2291|hsp_num:0	2350
NODE_48871_length_752_cov_9.83501_1 # 3 # 83 # 1 # ID=42231_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.617	NODE_48871_length_752_cov_9.83501_1 	3	83	+	Loose	500	20.4014	OXA-360	45.45	3001547	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGTTGCCGGAGGGCTGGCTCGACGACCCGGAAGATGACACCGTGCCCGAGGGTGCTGACATTATGCACTCAGGTGGGTAA	VLPEGWLDDPEDDTVPEGADIMHSGG	MKILILLPLLSCLSLTACSFAVSNSPSQITSTQSIQAIVKLFDQAQSSGVLVIQRGPHLQVYGNELSRAHTEYVPASTFKMLNALIGLQHGKATTNEIFKWDRKKRSFAAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQHIDNFWLVGPLKVTPKQEVKFASALAQEQLAFDPRFQQQVKTMLLLQERQAYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIVAFSLNMQMQSNMDPAIRLKILQQALAELGLYPKAEG	9.42	gnl|BL_ORD_ID|1121|hsp_num:0	1169
NODE_51834_length_713_cov_3.67325_1 # 1 # 153 # -1 # ID=44212_1;partial=10;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.281	NODE_51834_length_713_cov_3.67325_1 	1	153	-	Loose	550	21.9422	RlmA(II)	33.33	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGTACGAAAATCTAAGTATTGTTTATGATAAATTAATGGATGTTGATTACGATACTTATGCAAATATAATAGATCAAGAATTAGAGGATAAAAAAGGTCTTCTAATTCTTGATTTAGGTTGCGGTAGTGGAACGATGATTCCTTATCTGAAA	MYENLSIVYDKLMDVDYDTYANIIDQELEDKKGLLILDLGCGSGTMIPYLK	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	18.09	gnl|BL_ORD_ID|2126|hsp_num:0	2274
NODE_51865_length_713_cov_5.66413_1 # 1 # 153 # -1 # ID=44226_1;partial=10;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.281	NODE_51865_length_713_cov_5.66413_1 	1	153	-	Loose	400	23.483	kdpE	47.62	3003841	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	kdpDE	ATGTACGAAAATTTAAGTATTGTTTATGATAAATTAATGGATGTTGATTACGATACTTATGCTAATATAATAGCTCAAGAATTAGGAGATAAAAAGGATCTTCTAATTCTTGATTTAGGTTGCGGTAGTGGAACGATGATTCCTTATCTGAAA	MYENLSIVYDKLMDVDYDTYANIIAQELGDKKDLLILDLGCGSGTMIPYLK	MTNVLIVEDEQAIRRFLRTALEGDGMRVFEAETLQRGLLEAATRKPDLIILDLGLPDGDGIEFIRDLRQWSAVPVIVLSARSEESDKIAALDAGADDYLSKPFGIGELQARLRVALRRHSATTAPDPLVKFSDVTVDLAARVIHRGEEEVHLTPIEFRLLAVLLNNAGKVLTQRQLLNQVWGPNAVEHSHYLRIYMGHLRQKLEQDPARPRHFITETGIGYRFML	22.67	gnl|BL_ORD_ID|2171|hsp_num:0	2331
NODE_53878_length_689_cov_10.5394_1 # 3 # 83 # 1 # ID=45544_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.642	NODE_53878_length_689_cov_10.5394_1 	3	83	+	Loose	500	20.4014	OXA-360	45.45	3001547	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGTTGCCGGAGGGCTGGCTCGACGACCCGGAAGATGACACCGTGCCCGAGGGCGCCGACATTATGCACTCAGGTGGGTAA	VLPEGWLDDPEDDTVPEGADIMHSGG	MKILILLPLLSCLSLTACSFAVSNSPSQITSTQSIQAIVKLFDQAQSSGVLVIQRGPHLQVYGNELSRAHTEYVPASTFKMLNALIGLQHGKATTNEIFKWDRKKRSFAAWEKDMTLGQAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQHIDNFWLVGPLKVTPKQEVKFASALAQEQLAFDPRFQQQVKTMLLLQERQAYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIVAFSLNMQMQSNMDPAIRLKILQQALAELGLYPKAEG	9.42	gnl|BL_ORD_ID|1121|hsp_num:0	1169
NODE_54311_length_684_cov_2.39746_2 # 606 # 683 # 1 # ID=45831_2;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.513	NODE_54311_length_684_cov_2.39746_2 	606	683	+	Strict	1280	20.4014	macB	100.0	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGAAGTCAAGCATAAAGACTACTCCGAGTTCGGGATCGACATCCCCTATGGCCGTCGCTCGGGAAAGATTAAGACG	MEVKHKDYSEFGIDIPYGRRSGKIKT	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	4.04	gnl|BL_ORD_ID|462|hsp_num:0	487
NODE_58958_length_637_cov_5.88832_1 # 2 # 193 # -1 # ID=48758_1;partial=10;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.750	NODE_58958_length_637_cov_5.88832_1 	2	193	-	Loose	900	23.0978	basS	36.67	3003583	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACTGCTCACCCCGCTCCCGCCGATCCCGTCAATCCTACGGACGCCTCCGCTGAGACCCGAGGCCTGACGCCCAAGGCCCGTCAGGCGCTTGAGGGCCTGCCCCCGGCCCTGGCGGCCCTGGGGCACGCCTTCGTGCGCGCCGGGCACGAGATCGCCCTGGTCGGCGGACCCGTGCGGGACGCCTTCCTC	MTAHPAPADPVNPTDASAETRGLTPKARQALEGLPPALAALGHAFVRAGHEIALVGGPVRDAFL	MSRAAVPSVRRRLLVNLLVGFVLCWLSVAALTYHLSLKQVNRLFDDDMVDFGEAALRLLDLATEDQAGEDGSITEIIERSREAIQGLPLLRRESALGYALWRDGQPLLSSLNLPPEITAQGPGFSTVEAQGTHWRVLQLNIDGFQIWISENLIYRQHTMNLLLFYSLFPLLLALPLLGGLVWFGVARGLAPLREVQAEVQQRSARHLQPIAVEAVPLEIRGLIDELNLLLERLRTALEAERRLTSDAAHEIRTPLASLRTHAQVALRSEDPKAHARGLLQVSRSVERISTLMEQILLLARLDGDALLEQFHPVNLATLAEDVLSELARQAIDKDIELSLHQETVHVMGIDLWLKAMVGNLVGNALRYTPAGGQVEIRVENRAQHAVLRVRDNGPGVALEEQQAIFTRFYRSPATSSGEGSGLGLPIVKRIVELHFGSIGLGKGLEGKGLEVQVFLPKTQPDATRPPARGPDSGRSHI	13.42	gnl|BL_ORD_ID|2280|hsp_num:0	249
NODE_59713_length_629_cov_5.09408_2 # 523 # 627 # -1 # ID=49228_2;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.390	NODE_59713_length_629_cov_5.09408_2 	523	627	-	Strict	650	20.4014	vanD	100.0	3000005	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; van ligase	AATTACTTTGATGAGGGCAAAGACTGGTGGGGAAGTTTCTTTTGGACGGTATACAACCCTTGTAGGGATTGGTATATAGGTATTATAGCTTCAGAAACTGATTAA	NYFDEGKDWWGSFFWTVYNPCRDWYIGIIASETD	MYKLKIAVLFGGCSEEHDVSVKSAMEVAANINKEKYQPFYIGITKSGAWKLCDKPCRDWENYAGYPAVISPDRRIHGLLIQKDGGYESQPVDVVLPMIHGKFGEDGTIQGLLELSGIPYVGCDIQSSVICMDKSLAYMVVKNAGIEVPGFRVLQKGDSLEAETLSYPVFVKPARSGSSFGVNKVCRAEELQAAVTEAGKYDSKILVEEAVSGSEVGCAILGNGNDLITGEVDQIELKHGFFKIHQEAQPEKGSENAVIRVPAALPDEVREQIQETAKKIYRVLGCRGLARIDLFLREDGSIVLNEVNTMPGFTSYSRYPRMMTAAGFTLSEILDRLIGLSLRR	9.91	gnl|BL_ORD_ID|795|hsp_num:0	824
NODE_65309_length_580_cov_2.19048_1 # 2 # 70 # -1 # ID=52551_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.507	NODE_65309_length_580_cov_2.19048_1 	2	70	-	Loose	500	19.631	CTX-M-45	72.73	3001907	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	ATGAACCAGCCCATCAAAAGCAATCTTCACGAGCTGATTGACACCGCTGACAACATCCTGCTGCTGCAA	MNQPIKSNLHELIDTADNILLLQ	MVTKRVQRMMSAAAACIPLLLGSPTLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQVLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTARAGADVASLRWVMRWAKPSGAVGDVAQRQYDRAAGIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL	7.96	gnl|BL_ORD_ID|1660|hsp_num:0	1738
NODE_66329_length_572_cov_3.31335_1 # 1 # 570 # -1 # ID=53158_1;partial=11;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.346	NODE_66329_length_572_cov_3.31335_1 	1	570	-	Strict	1200	385.185	tetM	97.89	3000186	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	AGAGATGGAGTACAAGCACAAACTCGGATATTATTTCATGCACTAAATAAAATGGGTATTCCCACAATCTTTTTTATCAATAAGATTGACCAAAATGGGATTGATTTATCAACGGTTTATCAAGATATTAAAGAGAAACTTTCTATGGAAATTATAATCAAACAGAAAGTAGAACTGCACCCTAATATGTGTGTGATGAGCTGTACGGAATCTGAACAATGGGATACGGTAATAGAAGGAAATGATTACCTTTTGGAGAAATATATACTTGGGAAATCATTGGAGATATTAGAACTCGAACAAGAGGAAATCAGAAGATTTCAGAATTGCTCCTTGTACCCTGTTTATCACGGAAGTGCAAAAAGCAATATAGGGATTGAGCAGCTTATAGAAGTGATAACAAATAAATTTTATTCATCAACATACAGAAAGAAGTCTGAACTTTGCGGAAATGTCTTCAAAATTGAATATTCGGAAGAAAGACAACGTCTTGCATATGTACGCCTTTATGGCGGTGTCCTGCATTTGCGGGATTCGGTTAGAATATCGGAAAAGGAAAAAATAAAAATT	RDGVQAQTRILFHALNKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSMEIIIKQKVELHPNMCVMSCTESEQWDTVIEGNDYLLEKYILGKSLEILELEQEEIRRFQNCSLYPVYHGSAKSNIGIEQLIEVITNKFYSSTYRKKSELCGNVFKIEYSEERQRLAYVRLYGGVLHLRDSVRISEKEKIKI	MKIINIGVLAHVDAGKTTLTESLLYTSGAIAESGSVDTGTTRTDTTFLERQRGITIQTAVTSFQWKDIKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISARDGVQAQTRILFHALNKMGIPTIFFINKIDQNGIDLSTVYQDIKEKLSMEIIIKQKVELHPNMCVMSCTEPEQWDVVIEGNDYLLEKYTLGKSLEILELEQEEIRRFQNCSLYPVYHGSAKSNIGIEQLIEVITNKFYSSTYRKKSELCGNVFKIEYSEERQRLAYVRLYGGILHLRDSVRISEKEKIKITEMYTSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIENPLPLLQTTVEPSKPQQREMLLDALLEISDSDPLLQYYVDSTTHEIILSFLGKVQMEVTCALLQEKYHVEVKIKKPTVIYMERPLKKAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEGIRYGCEQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYLSFKIYAPQEYLSRAYNDAPKYCANIVDTQLKNNEVILSGEIPARCIQEYRNDLTFFTNGRSVCLTELKGYYVTTGESVCQPRRPNSRIDKVRYMFNKIT	29.73	gnl|BL_ORD_ID|1618|hsp_num:0	1692
NODE_67295_length_565_cov_2.06471_2 # 493 # 564 # 1 # ID=53702_2;partial=01;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.625	NODE_67295_length_565_cov_2.06471_2 	493	564	+	Loose	500	23.483	PER-7	39.13	3002369	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam; penem	antibiotic inactivation	PER beta-lactamase	ATGGCACACAAGAAGGGCGCGTCCTCGACGCGCAACGGTCGTGATTCCAACGCCCAGCGTCTCGGTGTGAAG	MAHKKGASSTRNGRDSNAQRLGVK	MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDQFSVPVQQLLQYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGVRAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQAAYQFELKKLSALSPN	7.79	gnl|BL_ORD_ID|830|hsp_num:0	863
NODE_70896_length_540_cov_2.84742_2 # 357 # 539 # 1 # ID=55711_2;partial=01;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.568	NODE_70896_length_540_cov_2.84742_2 	357	539	+	Loose	400	21.557	EBR-1 beta-lactamase	32.5	3000842	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	EBR beta-lactamase	ATGAAAAAAGCCCTTGCCCTTGCTATTCTTGCCGCCGCCTTCGGCAGCGCCCAGGCCGACACCTATAAAATCGACAGCCACCACGCCAACGCCCGTTTTGCTATCGACCACTTCAACACCAGCACCAACACCGGCGGCTTCTACAACCTTTCCGGTACCGTGGAATACAACCCGCAGGCCAAA	MKKALALAILAAAFGSAQADTYKIDSHHANARFAIDHFNTSTNTGGFYNLSGTVEYNPQAK	MKKLFSLIALIGSFAFGQIKPIQIDPINNNLFVYQTFNSFNGVEYNANGMYLVTNKGIVLFDVPWQKSQYQELNDMLQEKYNLPVIAVFATHSHDDRAGDLSFYNELNIPTYATSLTNSKLKKEGKATSKFEIELGKTYKFGNEKFVFEYFGEGHTSDNVVVWFPKYKVLNGGCLIKGADAVNLGYTGEANVVEWPKTVHKLVAKHPTIKQVIPGHDNWKATGHIENTFKLLEKK	25.96	gnl|BL_ORD_ID|1069|hsp_num:0	1119
NODE_74655_length_515_cov_4.68043_1 # 402 # 515 # 1 # ID=57767_1;partial=01;start_type=ATG;rbs_motif=GGGGT;rbs_spacer=4bp;gc_cont=0.509	NODE_74655_length_515_cov_4.68043_1 	402	515	+	Loose	1900	21.1718	acrD	50.0	3000491	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAAAAATGCTCGCATTTTTTTCATGGGTATCCGGGAAGGTGGCCGAAGGCCGGAAGGGGGAATACAAAACCGTGTTTGTCCCGCTTGGCGCTGTTTACAGGATGCTCACC	MKKMLAFFSWVSGKVAEGRKGEYKTVFVPLGAVYRMLT	MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE	3.66	gnl|BL_ORD_ID|1361|hsp_num:0	1427
NODE_263_length_46270_cov_6.79414_46 # 32952 # 33326 # -1 # ID=263_46;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.669	NODE_263_length_46270_cov_6.79414_46 	32952	33326	-	Strict	200	219.55	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin	86.18	3003395	protein variant model	K88R	n/a	aminoglycoside antibiotic	antibiotic target alteration	antibiotic resistant rpsL	GTGCCCACAATTCAGCAGCTGGTCCGCAAGGGCCGCTCGAGCAAAGTCGGGAAGTCCAAGACCCCGGCGCTCAAGGGGAGTCCCCAGCGCCGCGGCGTGTGCACCCGCGTCTTCACCACCACCCCGAAGAAGCCGAATTCGGCCCTTCGCAAGGTCGCCCGCGTCCGCCTGTCCTCCGGTATAGAGGTCACGGCCTACATTCCCGGCGAGGGGCACAATCTCCAGGAGCATTCGATCGTCCTCGTCCGCGGGGGCCGCGTCCGCGACCTCCCGGGTGTGCGCTACAGGATCGTCCGTGGCGCCCTCGACACCCAGGGAGTCAAGAACCGTCAGCAGGCCCGCAGCCGCTACGGCGCGAAGAAGGAGAAGAAGTAA	VPTIQQLVRKGRSSKVGKSKTPALKGSPQRRGVCTRVFTTTPKKPNSALRKVARVRLSSGIEVTAYIPGEGHNLQEHSIVLVRGGRVRDLPGVRYRIVRGALDTQGVKNRQQARSRYGAKKEKK	MPTIQQLVRKGRRDKISKVKTAALKGSPQRRGVCTRVYTTTPKKPNSALRKVARVKLTSQVEVTAYIPGEGHNLQEHSMVLVRGGRVKDLPGVRYKIIRGSLDTQGVKNRKQARSRYGAKKEKG	100.00	gnl|BL_ORD_ID|2026|hsp_num:0	1197
NODE_1858_length_12511_cov_22.9847_1 # 3 # 98 # -1 # ID=1858_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.542	NODE_1858_length_12511_cov_22.9847_1 	3	98	-	Strict	375	22.3274	Escherichia coli acrR with mutation conferring multidrug antibiotic resistance	100.0	3003807	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCAAGCAACCGTTTTTCAGGCTGCCCCACACTTAGGAATCCCATGTTCAGCAAAATCCGCCACCCCGATTACCGCCGCATGATTGAACAGCAC	MPSNRFSGCPTLRNPMFSKIRHPDYRRMIEQH	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	14.88	gnl|BL_ORD_ID|2160|hsp_num:0	2306
NODE_58515_length_641_cov_2.59898_2 # 567 # 641 # 1 # ID=48484_2;partial=01;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.493	NODE_58515_length_641_cov_2.59898_2 	567	641	+	Strict	390	20.0162	MexZ	100.0	3003709	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; acridine dye; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCAGTTGAAAATTCCTTACAGCAAGGGAAAGATGACGATCGAGGTGCCGGACGAAAACTTCCTCGGCGTACTC	MQLKIPYSKGKMTIEVPDENFLGVL	MARKTKEESQKTRDGILDAAERVFLEKGVGTTAMADLADAAGVSRGAVYGHYKNKIEVCLAMCDRAFGQIEVPDENARVPALDILLRAGMGFLRQCCEPGSVQRVLEILYLKCERSDENEPLLRRRELLEKQGQRFGLRQIRRAVERGELPARLDVELASIYLQSLWDGICGTLAWTERLRDDPWNRAERMFRAGLDSLRSSPYLLLADA	11.90	gnl|BL_ORD_ID|2120|hsp_num:0	2223
